FORMATO EUROPEO PER IL CURRICULUM...

F O R M A T O E U R O P E O

P E R I L C U R R I C U L U M

V I T A E

INFORMAZIONI PERSONALI

Nome Daniela

Indirizzo GALIMBERTI

Telefono 333 25 14 190

Fax 0250320430

E-mail [email protected]

CODICE FISCALE GLMDNL71E52C523J

Nazionalità Italiana

Data di nascita 12/05/1971

ESPERIENZA LAVORATIVA

• Date (da – a) Marzo 2006-oggi:

• Nome e indirizzo del datore di lavoro

Università di Milano

• Tipo di azienda o settore Università di Milano, Dipartimento di Scienze Neurologiche

• Tipo di impiego tecnico laureato categoria D2.

• Principali mansioni e responsabilità

• Date (da – a) 2005-2006


Associazione Amici del Centro Dino Ferrari

via Francesco Sforza, 35 - milano • Tipo di azienda o settore

• Tipo di impiego Contratto a progetto

• Principali mansioni e responsabilità studio del ruolo dell’infiammazione nella patogenesi della malattia di

Alzheimer.

• Date (da – a) 2001-2004


Dipartimento di Scienze Neurologiche dell’Università di Milano, IRCCS

Ospedale Maggiore Milano

via Francesco Sforza, 35 Milano

• Tipo di azienda o settore Università • Principali mansioni e responsabilità Dottorato di Ricerca in Scienze Neurologiche e del Dolore

• Date (da – a) 2000-2001


Centro Dino Ferrari dell'Università di Milano

via Francesco Sforza, 35 Milano

• Tipo di azienda o settore • Principali mansioni e responsabilità assegno di collaborazione all'attività di ricerca (concorso per titoli e

colloquio) nell'ambito del programma di ricerca finanziato dalla

Comunità Europea dal titolo: "Microglial activation in

neurodegeneration in Alzheimer's disease: a therapeutical target"

Pagina 2 di 33

Data emissione del presente modello: 09/01/2006

• Date (da – a) 2000

• Nome e indirizzo del datore di lavoro Ospedale Maggiore Policlinico di Milano – Clinica Neurologica

via Francesco Sforza, 35 Milano.

• Tipo di azienda o settore Ospedale

• Principali mansioni e responsabilità incarico di consulenza da parte nell'ambito del progetto di Ricerca

Finalizzata 1997 "La Sclerosi Multipla sperimentale: metodi innovativi

di valutazione dell'efficacia dei nuovi farmaci immunomodulatori"

• Date (da – a) 2000


Ospedale Maggiore Policlinico di Milano – Clinica Neurologica



• Tipo di impiego borsa di ricerca annuale (concorso per titoli e colloquio) sul tema: “I topi

transgenici come modelli sperimentali delle neuropatie ereditarie

dell’uomo”


• Date (da – a) 1999





• Tipo di impiego borsa di ricerca annuale (concorso per titoli e colloquio) sul tema:

“Studio del ruolo svolto dall'apoptosi nella regolazione dei processi

infiammatori e rigenerativi del sistema nervoso periferico” . Principali mansioni e responsabilità

• Date (da – a) 1998


Associazione "Amici del Centro Dino Ferrari"

via Francesco Sforza, 35 - Milano Tipo di azienda o settore

• Tipo di impiego borsa di studio dell'Associazione "Amici del Centro Dino Ferrari"

nell’ambito del progetto: "Effetto di sostanze ad azione

antiinfiammatoria sulla produzione di citochine proinfiammatorie e

radicali dell'azoto da parte di cellule microgliali trattate con i peptidi

A(1-42) e A(25-35)".


• Date (da – a) 1997





• Tipo di impiego incarico di consulenza da parte dell'Ospedale Maggiore di Milano

nell'ambito del progetto di ricerca corrente dal titolo: "Ruolo delle

molecole di adesione nelle miopatie infiammatorie e nella distrofia

muscolare di Duchenne", presso la Clinica Neurologica.


• Date (da – a) 1996-1997




Pagina 3 di 33



• Tipo di impiego borsa di ricerca annuale (concorso per titoli e colloquio) sul tema:

“Molecole proinfiammatorie nella patogenesi del danno cerebrale in

corso malattia di Alzheimer”, bandita dall’Ospedale Maggiore di

Milano, svolta presso la Clinica Neurologica dell’Ospedale Maggiore di

Milano. • Principali mansioni e responsabilità

• Date (da – a) 1996





• Tipo di impiego incarico di consulenza da parte dell'Ospedale Maggiore di Milano

nell'ambito del progetto Telethon dal titolo: "Involvement of adhesion

molecules in immune responses during inflammatory and degenerative

myopathies". • Principali mansioni e responsabilità

• Date (da – a) • Nome e indirizzo del datore di

lavoro Dipartimento di Genetica e Biologia dei Microrganismi dell’Università

Statale di Milano

Via Celoria 20. Milano • Tipo di azienda o settore Università

• Tipo di impiego Tesi sperimentale.Durante tale periodo, partecipazione al Progetto

Europeo di Sequenziamento del Genoma di Saccharomyces cerevisiae,

contribuendo alla determinazione della sequenza nucleotidica di parte

del cromosoma VII di S. cerevisiae. Tale argomento costituisce

l’oggetto principale della tesi sperimentale, dal titolo: “Sequenziamento

di una regione di 4382 bp del cromosoma VII di S. cerevisiae e analisi

funzionale di un gene compreso in essa”.


• Date (da – a) 1989


Farmitalia Carlo Erba di Milano

• Tipo di azienda o settore Industria Farmaceutica

• Tipo di impiego nell’ambito del corso di studi medi superiori, stage lavorativo presso la

Farmitalia Carlo Erba di Milano, in laboratori di ricerca farmaceutica.


ISTRUZIONE E FORMAZIONE

• Date (da – a) 2004 • Nome e tipo di istituto di istruzione

o formazione Università di Milano

• Principali materie / abilità professionali oggetto dello studio

Scienze Neurologiche e del Dolore, Università di Milano

• Qualifica conseguita Diploma di Dottorato

Pagina 4 di 33


• Date (da – a) 1997

• Nome e tipo di istituto di istruzione o formazione

Università di Milano


• Qualifica conseguita Attestato di abilitazione all’esercizio della professione di Biologo

• Date (da – a) 1996


Facoltà di Scienze Matematiche, Fisiche e Naturali dell’Università degli

Studi di Milano • Principali materie / abilità

professionali oggetto dello studio Scienze Biologiche, indirizzo Biomolecolare

• Qualifica conseguita Laurea in Scienze Biologiche, indirizzo Biomolecolare Milano,

conseguita con la votazione di 107/110.

• Date (da – a) 1990


Istituto superiore I.T.S.O.S. “M. Curie” (Istituto Tecnico Statale ad

Ordinamento Speciale) di Cernusco s/N


Chimica e biologia

• Qualifica conseguita Diploma di Maturità Professionale per Tecnico di Laboratorio chimico

biologico,votazione di 60/60

CAPACITÀ E COMPETENZE

PERSONALI Acquisite nel corso della vita e della

carriera ma non necessariamente riconosciute da certificati e diplomi

ufficiali.

PRIMA LINGUA italiano

ALTRE LINGUE

inglese • Capacità di lettura eccellente

• Capacità di scrittura eccellente • Capacità di espressione orale eccellente

ALTRE CAPACITÀ E COMPETENZE

PUBBLICAZIONI SU RIVISTE INTERNAZIONALI CENSITE

Pagina 5 di 33


1. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron PL,

Lipton JM, Catania A. Melanocortin peptides inhibit production of proinflammatory

cytokines and nitric oxide by activated microglia. Journal of Leukocyte Biology

1998;63:740-745.

2. Galimberti D, Baron PL, Meda L, Prat E, Scarpini E, Delgado R, Catania A, Lipton

JM, Scarlato G. -MSH peptides inhibit production of nitric oxide and tumor necrosis

factor- by microglial cells activated with -amyloid and interferon-. Biochemical

and Biophysical Research Communications 1999;263:251-256.

3. Prat E, Baron P, Meda L, Scarpini E, Galimberti D, Ardolino G, Catania A, Scarlato

G. The human astrocytoma cell line U373MG produces monocyte chemotactic protein

(MCP-1) upon stimulation with -amyloid protein. Neuroscience Letters

2000;283:177-180.

4. Baron PL, Galimberti D, Meda L, Prat E, Scarpini E, Conti G, Moggio M, Prelle A,

Scarlato G. Synergistic effect of -amyloid protein and Interferon- or nitric oxide

production by C2C12 muscle cells. Brain 2000;123:374-379.

5. Baron P, Galimberti D, Meda L, Scarpini E, Conti G, Cogiamanian F, Scarlato G.

Production of IL-6 by human myoblasts stimulated with A: relevance in the

pathogenesis of IBM. Neurology 2001;57:1561-1565.

6. Rigamonti AE, Pincelli AI, Corrà B, Viarengo R, Bonomo SM, Galimberti D, Scacchi

M, Scarpini E, Cavagnini F, Müller EE. Plasma ghrelin concentrations in elderly

subjects: comparison with anorexic and obese patients. Journal of Endocrinology

2002;175:R1-5.

7. Scarpini E, Galimberti D, Baron PL, Clerici R, Ronzoni M, Conti G,

Scarlato G. IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients

with different clinical subtypes of the disease. Journal of the Neurological Sciences

2002;195: 41-46.

8. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P, on behalf of the DIAR

Group. Chemokines in CSF and serum from patients with different types of dementia.

Annals of Neurology 2003; 53: 547-548.

9. Galimberti D, Bresolin N, Scarpini E. Chemokine network in Multiple Sclerosis: role

in the pathogenesis and targeting for future treatments. Expert Reviews

Neurotherapeutics 2004; 4(3): 89-103.

10. Conti G, Rostami A, Scarpini E, Baron P, Galimberti D, Bresolin N, Contri M, Palumbo C, De Pol A. Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. Experimental Neurology 2004;187: 350-358.

11. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron PL, Conti G, Bresolin N, Scarpini E. MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiology of Aging 2004;25(9):1169-1173.

12. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E, Cutter GR, Mariani

C, Forloni G, Pettenati C, Baron PL, Conti G, Bresolin N, Scarpini E. CCR2-64I

polymorphism and CCR5∆32 deletion in patients with Alzheimer’s disease. Journal

of the Neurological Sciences 2004; 225: 79-83.

13. Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici

R, Galbiati S, Virgilio R, Pomati S, Comi GP,Mariani C, Forloni G, Bresolin N,

Scarpini E. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and

homocysteine levels in AD patients. Neurobiology of Aging, 2005; 26(6): 789-794.

14. Del Bo R, Scarlato, M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP. VEGF gene variability is associated with increased risk of Alzheimer’s disease. Annals of Neurology, 2005; 57: 373-78

15. Venturelli E, Galimberti D, Lovati C, Fenoglio C, Mariani C, Forloni G, Bresolin

N, Scarpini E. The T-786C NOS3 polymorphism in Alzheimer’s disease: association and influence on gene expression. Neuroscience Letters 2005;

382: 300-303.

Pagina 6 di 33


16. Galimberti D, Fenoglio C, Clerici R, Comi C, De Riz M, Rottoli M, Piccio L, Ronzoni M, Venturelli E, Monaco F, Poloni M, Bresolin N, Scarpini E. E-selectin A561C and G98T polymorphisms influence susceptibility and progression of Multiple Sclerosis. Journal of Neuroimmunology

2005;165:201-205.

17. Galimberti D, Venturelli E, Gatti A, Lovati C, Fenoglio C, Mariani C, Forloni G,

Bresolin N, Scarpini E. Association of neuronal Nitric Oxide Synthase C276T

polymorphism with Alzheimer’s disease. Journal of Neurology 2005; 252: 985-986.

18. Scalabrini D, Galimberti D, Fenoglio C, Comi C, De Riz M, Venturelli E, Castelli L, Piccio L, Ronzoni M, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with Multiple Sclerosis. Neuroscience Letters 2005;

388: 149-152. 19. Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, Scarpini E, Bresolin

N, Wharton SB, Shaw PJ, Silani V. Production of monocyte chemoattractant protein-1

in amyotrophic lateral sclerosis. Muscle & Nerve 2005; 32(4): 541-544.

20. Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, Fenoglio C,

Venturelli E, Baron PL, Bresolin N, Scarpini E. Oxidative imbalance in patients with

Mild Cognitive Impairment and Alzheimer's disease. Neurobiology of Aging

2006;27(2):262-269.

21. Del Bo, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, Galbiati S, Virgilio R, Galimberti D, Ferrarese C, Scarpini E, Bresolin N, Comi GP. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiology of Aging 2006;27(5):770.

22. Scarpini E, Galimberti D, Guidi I, Bresolin N, Scheltens P. Progressive, isolated language disturbance: its significance in a 65-year-old-man. A case report with implications for treatment and review of literature. Journal of the

Neurological Sciences 2006;240:45-51.

23. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg

YAL, Bresolin N, Scarpini E. Intrathecal chemokine levels in Alzheimer’s disease and

Frontotemporal Lobar degeneration. Neurology 2006; 66(1):146-147.

24. Fenoglio C, Galimberti D, Ban M, Maranian M, Scalabrini D, Venturelli E, Piccio L,

De Riz M, Yeo T, Goris A, Gray J, Bresolin N, Scarpini E, Compston A, Sawcer S.

SELPLG and SELP single nucleotide polymorphisms in multiple sclerosis.

Neuroscience Letters 2006; 394(2): 92-96.

25. Saltini G, Dominici R, Lovati C, Cattaneo M, Michelini S, Malferrari G, Caprera A,

Milanesi L, Finazzi D, Bertora P,Scarpini E, Galimberti D, Venturelli E, Musicco M,

Adorni F, Mariani C, Biunno I. A novel polymorphism in SEL1L confers

susceptibility to Alzheimer’s disease. Neuroscience Letters 2006;398(1-2):53-8.

26. Pesaresi M, Lovati C, Bertora P, Mailland E, Galimberti D, Scarpini E, Quadri P,

Forloni G, Mariani C. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and

mild cognitive impairment. Neurobiology of Aging 2006; 27: 904-905.

27. Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corrà B, Scalabrini D,

Clerici F, Mariani C, Bresolin N, Scarpini E. Serum MCP-1 levels are increased in

Mild Cognitive Impairment and mild Alzheimer's disease. Neurobiology of Aging

2006; 27: 1763-1768.

28. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in Mild Cognitive Impairment and Alzheimer's disease. Archives of Neurology 2006;63:538-543.

29. E. Scarpini, D. Galimberti, N. Bresolin. Genetics and neurobiology of Frontotemporal

Lobar Degeneration. Neurological Sciences 2006, 27 Suppl.1: S32-S34.

30. Giunta M, Rigamonti AE, Scarpini E, Galimberti D, Bonomo SM, Venturelli E, Müller

EE, Cella SG. The leukocyte expression of CD36 is low in patients with Alzheimer’s

disease and Mild Cognitive Impairment. Neurobiology of Aging 2007, 28(4):515-518.

Pagina 7 di 33


31. Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B,

Scalabrini D, Clerici F, Mariani C, Forloni G, Bresolin N, Scarpini E. Candidate gene

analysis of IP-10 gene in patients with Alzheimer's disease. Neuroscience Letters

2006 ; 404: 217-221.

32. Fenoglio C, Galimberti D, Piccio L, Scalabrini D, Panina P, Buonsanti C, Venturelli E,

Lovati C, Baron P, Forloni G, Mariani C, Bresolin N, Scarpini E.

Absence of polymorphisms in TREM-2 coding region in patients with early onset

dementia. Neuroscience letters 2007; 411: 133-137.

33. Albani D, Batelli S, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A,

Franceschi M, Piras MR, Confaloni A, Roiter I, Artuso V, Forloni G. Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population.

Neurobiology of Aging 2007, 28(11):1682-1688.

34. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Lovati C,

Mariani C, Monaco F, Bresolin N, Scarpini E.

IP-10 haplotypes and Multiple Sclerosis: association and correlation with clinical

course. European Journal of Neurology 2007; 14: 162-167.

35. Galimberti D, Venturelli E, Fenoglio C, Lovati C, Guidi I, Corrà B, Scalabrini D,

Clerici F, Mariani C, Bresolin N, Scarpini E. IP-10 serum levels in Mild Cognitive

Impairment and Alzheimer’s disease. European Journal of neurology, 2007; 14: e3-

e4.

36. Galimberti D, Scarpini E, Venturelli E, Strobel A, Herterichc S, Fenoglio C, Guidi I,

Scalabrini D, Cortini F, Bresolin N, Lesch KP, Reif A. Association of a NOS1

promoter repeat with Alzheimer’s disease. Neurobiology of Aging 2008; 29(9): 1359-

1365.

37. Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco

M, Dominici R, Albertini A, Finazzi D. Interaction between the APOE varepsilon4

allele and the APH-1b c+651T>G SNP in Alzheimer's disease. Neurobiology of

Aging 2008; 29(10):1494-1501.

38. Castelli L, Comi C, Chiocchetti A, Nicola S, Mesturini R, Giordano M, D'Alfonso S,

Cerutti E, Galimberti D, Fenoglio C, Tesser F, Yagi J, Rojo JM, Perla F, Leone M,

Scarpini E, Monaco F, Dianzani U. ICOS gene haplotypes correlate with IL10

secretion and multiple sclerosis evolution. Journal of Neuroimmunology 2007,

186(1-2):193-198.

39. Lovati C, Galimberti D, Pomati S, Capiluppi E, Dolci A, Scapellato L, Rosa S,

Mailland E, Suardelli M, Vanotti A, Clerici F, Santarato D, Panteghini M, Scarpini E,

Mariani C, Bertora P. Serum folate concentrations in patients with cortical and

subcortical dementia. Neuroscience Letters 2007; 420(3):213-216.

40. Del Bo R, Ghezzi S, Scarlato M, Albani D, Galimberti D, Lucca U, Tettamanti M,

Scarpini E, Forloni G, Bresolin N, Comi GP. Role of VEGF gene variability in

longevity: A lesson from the Italian population. Neurobiology of Aging 2008; 29(12):

1917-1922.

41. Bonomo SM, Rigamonti AE, Giunta M, Galimberti D, Guaita A, Gagliano MG,

Muller EE, Cella SG. Menopausal transition: A possible risk factor for brain

pathologic events. Neurobiol Aging 2009; 30(1):71-80.

42. Scalabrini D, Fenoglio C, Scarpini E, De Riz M, Comi C, Venturelli E, Cortini F, Piola

M, Villa C, Naldi P, Monaco F, Bresolin N, Galimberti D. Candidate gene analysis of

SPARCL1 gene in patients with Multiple Sclerosis. Neuroscience Letters 2007; 425:

173-176.

43. Galimberti D, Fenoglio C, Comi C, Scalabrini D, De Riz M, Leone M, Venturelli E,

Cortini F, Piola M, Monaco F, Bresolin N, Scarpini E. MDC/CCL22 intrathecal levels

in patients with multiple sclerosis. Multiple Sclerosis 2008; 14: 547-549.

44. Bersano A, Del Bo R, Lamperti C, Ghezzi S, Fagiolari G, Fortunato F, Ballabio E,

Moggio M, Candelise L, Galimberti D, Virgilio R, Lanfranconi S, Torrente Y, Carpo

M, Bresolin N, Comi GP, Corti S. Inclusion body myopathy and frontotemporal

dementia caused by a novel VCP mutation. Neurobiology of Aging 2009;30(5):752-

758.

45. D'Alfonso S, Bolognesi E, Guerini FR, Barizzone N, Bocca S, Ferrante D, Castelli L,

Pagina 8 di 33


Bergamaschi L, Agliardi C, Ferrante P, Naldi P, Leone M, Caputo D, Ballerini C,

Salvetti M, Galimberti D, Massacesi L, Trojano M, Momigliano-Richiardi P. A

sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in

Italy. Genes & Immunity 2008;9(1):7-15.

46. Galimberti D, Venturelli E, Fenoglio C, Guidi I, Villa C, Bergamaschini L, Cortini F,

Scalabrini D, Baron P, Vergani C, Bresolin N, Scarpini E. Intrathecal levels of IL-6,

IL-11 and LIF in Alzheimer’s disease and Frontotemporal Lobar Degeneration.

Journal of Neurology 2008;255(4): 539-544.

47. Galimberti D, Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E, Cortini F,

Piola M, Leone M, Dianzani U, D’Alfonso S, Monaco F, Bresolin N, Scarpini E.

Gender-specific influence of the chromosome 16 chemokine gene cluster on the

susceptibility to multiple sclerosis. Journal of the Neurological Sciences 2008; 267:

86-90.

48. Venturelli E, Villa C, Scarpini E, Fenoglio C, Guidi I, Lovati C, Marcone A, Cortini F,

Scalabrini D, Clerici F, Bresolin N, Mariani C, Cappa S, Galimberti D. Neuronal

Nitric Oxide Synthase C276T polymorphism increases the risk for Frontotemporal

Lobar Degeneration. European Journal of Neurology 2008; 15: 77-81.

49. Galimberti D, Fenoglio C, Scarpini E. Inflammation in neurodegenerative disorders:

friend or foe? Current Aging Science 2008; 1: 30-41.

50. Cappellano G, Orilieri E, Comi C, Chiocchetti A, Bocca S, Boggio E, Bernardone IS,

Cometa A, Clementi R, Barizzone N, D'Alfonso S, Corrado L, Galimberti D, Scarpini

E, Guerini FR, Caputo D, Paolicelli D, Trojano M, Figà-Talamanca L, Salvetti M,

Perla F, Leone M, Monaco F, Dianzani U. Variations of the perforin gene in patients

with multiple sclerosis. Genes & Immunity 2008, 9(5):438-444.

51. Reif A, Scarpini E, Venturelli E, Töpner T, Fenoglio C, Lesch KP, Galimberti D. The

functional MAOA-uVNTR promoter polymorphism in patients with frontotemporal

dementia. European Journal of Neurology 2008;15(6):637-639.

52. Borroni B, Archetti S, Alberici A, Agosti C, Gennarelli M, Bigni B, Bonvicini C,

Ferrari M, Bellelli G, Galimberti D, Scarpini E, Di Lorenzo D, Caimi L, Caltagirone

C, Di Luca M, Padovani A. Progranulin genetic variations in frontotemporal lobar

degeneration: evidence for low mutation frequency in an Italian clinical series.

Neurogenetics 2008;9(3):197-205.

53. Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D,

Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Variation in MAPT is

associated with cerebrospinal fluid tau levels in the presence of amyloid-beta

deposition. Proceedings of the National Academy of Sciences USA

2008;105(23):8050-8054.

54. Dreses-Werringloer U, Lambert J, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A,

Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E,

Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett KJ, Campagne F,

Marambaud P. A polymorphism in CALHM1 influences Ca2+ homeostasis, A levels,

and Alzheimer’s disease risk. Cell 2008; 133: 1-13.

55. International Multiple Sclerosis Genetics Consortium (IMSGC). Refining genetic

associations in multiple sclerosis. Lancet Neurology 2008;7(7):567-569.

56. Benerini Gatta L, Vitali M, Zanola A, Venturelli E, Fenoglio C, Galimberti D, Scarpini

E, Finazzi D. Polymorphisms in the LOC387715/ARMS2 Putative Gene and the Risk

for Alzheimer's Disease. Dement Geriatr Cogn Disord 2008;26(2):169-174.

57. Borroni B, Ghezzi S, Agosti C, Archetti S, Fenoglio C, Galimberti D, Scarpini E, Di

Luca M, Bresolin N, Comi GP, Padovani A, Del Bo R. Preliminary Evidence that

VEGF Genetic Variability Confers Susceptibility to Frontotemporal Lobar

Degeneration. Rejuvenation Research 2008;11(4):773-780.

58. Cortini F, Fenoglio C, Guidi I, Venturelli E, Pomati S, Marcone A, Scalabrini D, Villa

C, Clerici F, Dalla Valle E, Mariani C, Cappa S, Bresolin N, Scarpini E, Galimberti D.

Novel exon 1 progranulin gene variant in Alzheimer's disease. European Journal of

Neurology 2008, 15: 1111–1117.

59. Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J 2nd,

Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M,

Pagina 9 di 33


Cross AH. Identification of soluble TREM-2 in the cerebrospinal fluid and its

association with multiple sclerosis and CNS inflammation. Brain 2008; 131(Pt 11):

3081-3091.

60. Albani D, Prato F, Fenoglio C, Batelli S, Dusi S, De Mauro S, Polito L, Lovati C,

Galimberti D, Mariani C, Scarpini E, Forloni G. Association study to evaluate the

serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration

in Italy. Journal of Human Genetics 2008 2008;53(11-12):1029-33.

61. Galimberti D, Scarpini E. New Perspectives for the Treatment of Alzheimer’s Disease.

The Open Geriatric Medicine Journal 2008;1:33-42.

62. Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Ghidoni R, Cortini F,

Scalabrini D, Gallone S, Rainero I, Mandelli A, Restelli I, Binetti G, Cappa S, Mariani

C, Giordana MT, Bresolin N, Scarpini E, Galimberti D. The NOS3 G894T

(Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration.

European Journal of Neurology 2009; 16: 37-42.

63. Hansmannel F, Lendon C, Pasquier F, Dumont J, Hannequin D, Chapuis J, Laumet G,

Ayral AM, Galimberti D, Scarpini E, Campion D, Amouyel P, Lambert JC. Is the

ornithine transcarbamylase gene a genetic determinant of Alzheimer's disease?

Neuroscience Letters 2009;449(1):76-80.

64. Fenoglio C, Scalabrini D, Piccio L, De Riz M, Venturelli E, Cortini F, Villa C,

Serpente M, Parks B, Rinker J, Cross AH, Bresolin N, Scarpini E, Galimberti D.

Candidate gene analysis of selectin cluster in patients with multiple sclerosis. Journal

of Neurology 2009; 256:832–833.

65. Albani D, Batelli S, Polito L, Prato F, Pesaresi M, Gajo GB, De Angeli S, Zanardo A,

Galimberti D, Scarpini E, Gallucci M, Forloni G. Interleukin-6 plasma level increases

with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with

a sex-specific contribution of rs1800795 polymorphism. Age (Dordr) 2009;31(2):155-

62.

66. Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L, Ghidoni R,

Gallone S, Cortini F, Scalabrini D, Serpente M, Binetti G, Cappa S, Mariani C,

Rainero I, Bresolin N, Scarpini E, Galimberti D. CCL8/MCP-2 association analysis in

patients with Alzheimer’s disease and Frontotemporal Lobar Degeneration. Journal of

Neurology 2009;256:1379–1381.

67. Galimberti D Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L,

Cortini F, Scalabrini D, Perini L, Restelli I, Binetti G, Cappa S, Mariani C, Bresolin N,

Scarpini E. MCP-1 A-2518G polymorphism: effect on susceptibility for

Frontotemporal Lobar Degeneration and on cerebrospinal fluid MCP-1 levels. Journal

of Alzheimer Disease 2009; 17: 125-133.

68. Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L, Gallone S,

Scalabrini D, Cortini F, Serpente M, Martinelli Boneschi F, Cappa S, Binetti G,

Mariani C, Rainero I, Giordana MT, Bresolin N, Scarpini E, Galimberti D. DCUN1D1

is a risk factor for Frontotemporal Lobar Degeneration. European Journal of

Neurology 2009; 16: 870–873.

69. Fenoglio C, Galimberti D, Cortini F, Kauwe JSK, Cruchaga C, Venturelli E, Villa C, Serpente M, Scalabrini D, Mayo K, Piccio LM, , Clerici F, Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Scarpini E. rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer’s disease. Journal of Alzheimer Disease, 2009;

18(3): 603-12.

70. Albani D, Vittori A, Batelli S, Polito L, De Mauro S, Galimberti D, Scarpini E, Lovati C, Mariani C, Forloni G. The serotonin transporter gene polymorphic element 5-HTTLPR increases sporadic parkinson’s disease risk in Italy. European Neurology 2009;62(2):120-3.

71. Goumidi L, Flamant F, Lendon C, Galimberti D, Pasquier F, Scarpini E, Hannequin D,

Campion D, Amouyel P, Lambert JC, Meirhaeghe A. Study of thyroid hormone

receptor alpha gene polymorphisms on Alzheimer's disease. Neurobiology of Aging

2009 May 6 [Epub ahead of print]

72. Scarpini E, Galimberti D. Alzheimer’s disease: from pathogenesis to novel therapeutic

approaches. Therapy 2009; 6(2): 259-277.

Pagina 10 di 33


73. Del Bo R, Corti S, Santoro D, Ghione I, Fenoglio C, Ghezzi S, Ranieri M, Galimberti

D, Mancuso M, Siciliano G, Briani C, Murri L, Scarpini E, Schymick JC, Traynor BJ,

Bresolin N, Comi GP. No major progranulin genetic variability contribution to disease

etiopathogenesis in an ALS Italian cohort. Neurobiology of Aging 2009 Jul 24. [Epub

ahead of print]

74. Albani D, Prato F, Tettamanti M, Lovati C, Galimberti D, Restelli I, Mariani C, Quadri

PL, Scarpini E, Lucca U, Forloni G. The Serotonin Transporter Promoter Polymorphic

Region is not a Risk Factor for Alzheimer's Disease Related Behavioral Disturbances.

Journal of Alzheimer’s Disease 2009; 18(1): 125-30.

75. Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F, Venturelli E, Restelli

I, Cantoni C, Bresolin N, Monaco F, Scarpini E, Galimberti D. Progranulin plasma

levels as potential biomarker for the identification of GRN deletion carriers. A case

with atypical onset as clinical amnestic Mild Cognitive Impairment converted to

Alzheimer's disease. Journal of the Neurological Sciences 2009; 287(1-2): 291-3.

76. Benussi L, Ghidoni R, Galimberti D, Boccardi M, Fenoglio C, Scarpini E, Frisoni GB,

Binetti G. The CST3 B haplotype is associated with frontotemporal lobar

degeneration. European Journal of Neurology 2009 Aug 5. [Epub ahead of print]

77. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O,

Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F,

Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A,

Helisalmi S, Porcellini E, Hanon O, the European Alzheimer's Disease Initiative

Investigators, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T,

Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Piccardi P, Annoni G,

Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanché H,

Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alpérovitch A, Lathrop M,

Amouyel P. Genome-wide association study identifies variants at CLU and CR1

associated with Alzheimer's disease. Nature Genetics 2009; 41(10):1094-9.

78. Gallone S, Giordana MT, Scarpini E, Rainero I, Rubino E, Fenoglio P, Galimberti D,

Grifoni S, Venturelli E, Acutis PL, Peletto S, Maniaci MG, Ferrero P, Zotta M, Pinessi

L. Absence of TARDBP Gene Mutations in an Italian Series of Patients with

Frontotemporal Lobar Degeneration. Dementia and Geriatric Cognitive Disorders

2009;28(3):239-43.

79. Vitali M, Venturelli E, Galimberti D, Benerini Gatta L, Scarpini E, Finazzi D.

Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in

Alzheimer's disease. Journal of Neural Transmission 2009; 116(12):1635-41.

80. Braghin E, Galimberti D, Scarpini E, Bresolin N, Baron P. Alpha1-antichymotrypsin

induces TNF-alpha production and NF-kappaB activation in the murine N9 microglial

cell line. Neuroscience Letters 2009; 467(1): 40-2.

81. Laumet G, Petitprez V, Sillaire A, Ayral AM, Hansmanel F, Chapuis J, Hannequin D,

Pasquier F, Scarpini E, Galimberti D, Lendon C, Campion D, Amouyel P, Lambert JC.

A study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes

and Alzheimer's disease. Neuroscience Letters 2010;468(1):1-2.

82. Bergamaschi L, Leone MA, Fasano ME, Guerini FR, Ferrante D, Bolognesi E,

Barizzone N, Corrado L, Naldi P, Agliardi C, Dametto E, Salvetti M, Visconti A,

Galimberti D, Scarpini E, Vercellino M, Bergamaschi R, Monaco F, Caputo D,

Momigliano-Richiardi P, D'Alfonso S. HLA-class I markers and multiple sclerosis

susceptibility in the Italian population. Genes & Immunity 2009 Nov 12. [Epub ahead

of print]

83. Galimberti D, Scarpini E. Treatment of Alzheimer’s Disease: symptomatic and

disease-modifying approaches. Current Aging Science 2010; 3(1): 46-56.

84. Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, Galimberti D,

Ghidoni R, Gonella D, Novello C, Pollero V, Perroni L, Odetti P, Scarpini E, Binetti

G, Tabaton M. The H1 Haplotype of the Tau Gene (MAPT) is Associated with Mild

Cognitive Impairment. Journal of Alzheimer’s Disease 2010; 19(3): 909-14.

85. Villa C, Venturelli E, Fenoglio C, De Riz M, Scalabrini D, Cortini F, Serpente M,

Cantoni C, Bresolin N, Scarpini E, Galimberti D. Candidate gene analysis of

semaphorins in patients with Alzheimer's disease. Neurological Sciences 2010;

31:169–73.

Pagina 11 di 33


86. De Riz M, Galimberti D, Fenoglio C, Piccio LM, Scalabrini D, Venturelli E,

Pietroboni A, Piola M, Naismith RT, Parks BJ, Fumagalli G, Bresolin N, Cross AH,

Scarpini E. Cerebrospinal fluid progranulin levels in patients with different multiple

sclerosis subtypes. Neuroscience Letters 2010;469:234-6.

87. Comi C, Carecchio M, Chiocchetti A, Nicola S, Galimberti D, Fenoglio C, Cappellano

G, Monaco F, Scarpini E, Dianzani U. Osteopontin is Increased in the Cerebrospinal

Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive

Decline. Journal of Alzheimer’s Disease 2010;19(4):1143-8.

88. Galimberti D, Fenoglio C, Cortini F, Serpente M, Venturelli E, Villa C, Clerici F,

Marcone A, Benussi L, Ghidoni R, Gallone S, Scalabrini D, Restelli I, Boneschi FM,

Cappa S, Binetti G, Mariani C, Rainero I, Giordana MT, Bresolin N, Scarpini E. GRN

variability contributes to sporadic frontotemporal lobar degeneration. Journal of

Alzheimer’s Disease 2010;19(1):171-7.

89. Cantoni C, Fenoglio C, Cortini F, Venturelli E, Villa C, Clerici F, Marcone A, Benussi

L, Ghidoni R, Gallone S, Scalabrini D, Franceschi M, Cappa S, Binetti G, Mariani C,

Rainero I, Giordana MT, Bresolin N, Scarpini E, Galimberti D. FUS/TLS Genetic

Variability in Sporadic Frontotemporal Lobar Degeneration. Journal of Alzheimer’s

Disease 2010;19(4):1317-22.

90. Martinelli-Boneschi F, Esposito F, Scalabrini D, Fenoglio C, Rodegher ME, Brambilla

P, Colombo B, Ghezzi A, Capra R, Collimedaglia L, Coniglio G, De Riz M, Serpente

M, Cantoni C, Scarpini E, Martinelli V, Galimberti D, Comi G. Lack of replication of

KIF1B gene in an Italian primary progressive multiple sclerosis cohort. European

Journal of Neurology 2010 Jan 7. [Epub ahead of print]

91. Mishto M, Bellavista E, Ligorio C, Textoris-Taube K, Santoro A, Giordano M,

D'Alfonso S, Listì F, Nacmias B, Cellini E, Leone M, Grimaldi LM, Fenoglio C,

Esposito F, Martinelli-Boneschi F, Galimberti D, Scarpini E, Seifert U, Amato MP,

Caruso C, Foschini MP, Kloetzel PM, Franceschi C. Immunoproteasome LMP2 60HH

Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple

Sclerosis in Italian Female Population. PLoS One 2010;5(2):e9287.

92. Scalabrino G, Galimberti D, Mutti E, Scalabrini D, Veber D, De Riz M, Bamonti F,

Capello E, Mancardi GL, Scarpini E. Loss of epidermal growth factor regulation by

cobalamin in multiple sclerosis. Brain Research 2010 Mar 26. [Epub ahead of print]


CAPITOLI DI LIBRI

1. Scarpini E, Galimberti D. Chemokines and their receptors in multiple sclerosis:

from the role in the pathogenesis to the targeting for future treatments. In: “Treatment and Management of Multiple Sclerosis Research” 2005: 89-

105. Novapublishers, New York, USA (Editor: Frank Columbus). 2. Galimberti D, Fenoglio C, Scarpini E. Immunological Aspects in

Neurodegenerative Disorders. In: “Neuroimmunology Research Focus”

2007: 5-42. Novapublishers, New York, USA (Editor: Paulo V. Broglio).

3. Galimberti D, Scarpini E. Role of chemokines in neurodegeneration. In: “Progress in chemokine research” 2007: 141-147. Novapublishers, New

York, USA (Editor: WP Linkes).

4. Galimberti D, Fenoglio C, Scarpini E. Early onset dementia: role of genetics in the pathogenesis of Alzheimer’s disease and Frontotemporal Lobar Degeneration. In: “Alzheimer Disease in the Middle-Aged” 2008: 329-245. Novapublishers, New York, USA (Editor: Hyun Sil Jeong)

5. Galimberti D, Fenoglio C, Scarpini E. Alzheimer’s disease: from pathogenesis

to new perspectives for treatment. In: “A Multidisciplinary Approach to Dissect the Alzheimer’s Pathology” 2008: 111-129. Transworld Research

Network, 37/661 (2), Fort P.O., Trivandrum-695 023, Kerala, India (Editors: Roberto Dominici and Ida Biunno)

Pagina 12 di 33


6. Guidi I, Galimberti D. Mild Cognitive Impairment. In: “BioMarkers for Early

Diagnosis of Alzheimer's Disease” 2008, Novapublishers, New York, USA

(Editors: Daniela Galimberti and Elio Scarpini).

7. Galimberti D, Fenoglio C, Scarpini E. Novel Therapies for Alzheimer's Disease: Potentially Disease Modifying Drugs. In: “Cognitive Impairment: causes, diagnosis and treatments”, in press, Novapublishers, New York, USA (Editor:

Melanie L. Landow).

8. Fenoglio C, Scarpini E, Galimberti D. Gender-related genetic and biochemical differences: influence on susceptibility and course of multiple sclerosis. In: “Women and Multiple Sclerosis” in press, Novapublishers, New York, USA

(Editor: Duane O’Mahoni and Anrai de Burca).


PARTECIPAZIONE A CONGRESSI

1. Prat E, Meda L, Baron PL, Galimberti D, Ardolino G, Scarpini E, Scarlato G. Effect of

amyloid-associated proteins on proinflammatory function of cultured human

monocytes and mouse microglia. Clinical Neuropathology 16 (3):165 (1997).

XXXIII Annual Meeting of the Italian Neuropathological Association, 1997, Pisa,

Italy.

2. Prat E, Meda L, Baron PL, Galimberti D, Ardolino G, Scarpini E, Scarlato G. Effect

of amyloid associated protein on proinflammatory function of cultured human

monocytes and mouse microglia. Journal of Neurology 244 (3):S29 (1997). VII

Meeting of the European Neurological Society, 1997, Rhodes.

3. Baron PL, Meda ML, Prat E, Galimberti D, Ardolino G, Scarpini E, Scarlato G.

Network of proinflammatory, chemotactic and inhibitory cytokines from amyloid

deposition and phagocyte activation in Alzheimer's disease. Journal of the

Neurological Sciences 150 S:S 17 (1997). XVI World Congress of Neurology,

1997, Buenos Aires, Argentina.

4. Galimberti D, Baron PL, Meda L, Prat E, Agazzi P, Raimondi M, Ardolino G, Scarpini

E, Scarlato G. Melanocortin peptides inhibit production of nitric oxide by -amyloid

activated microglia. Journal of Neurology 245 (6/7): 397 (1998). VIII Meeting of the

European Neurological Society, June 6-10,1998, Nice, France.

5. Galimberti D, Baron PL, Meda L, Prat E, Catania A, Scarpini E, Conti G, Scarlato G.

-MSH peptides inhibit production of TNF and nitric oxide by A[25-35]-activated

microglia. Neurology 50 (4) suppl. 4 (1998). 50th Meeting of the American Academy

of Neurology, 1998, Minneapolis, USA.

6. Galimberti D, Baron PL, Meda L, Prat E, Agazzi P, Raimondi M, Ardolino G, Scarpini

E, Scarlato G. -melanocyte stimulating hormone inhibits production of nitric oxide

by -amyloid activated microglia. Clinical Neuropathology 17(3) (1998). XXXIV

Annual Meeting of the Italian Neuropathological Association, 1998, Bosisio Parini,

Italy.

7. Baron PL, Meda L, Galimberti D, Prat E, Scarpini E, Moggio M, Conti G, Scarlato G.

-amyloid peptides induce production of nitric oxide by C2C12 muscle cells. Muscle

& Nerve 7: 129 (1998). IX International Congress of Neuromuscular Diseases, 1998,

Adelaide, Australia.

8. Prat E, Meda L, Galimberti D, Ardolino G, Agazzi P, Tadeo S, Baron PL, Scarpini E,

Conti G, Scarlato G. -Amyloid peptides induce the production of MCP-1 in cultured

human astrocytes. Journal of Neurology 246, suppl.1: I/ 104 (1999). IX Meeting of

the European Neurological Society, 5-9 June, 1999, Milan, Italy.

9. Prat E, Baron PL, Meda L, Scarpini E, Conti G, Galimberti D, Ardolino G, Agazzi P,

Tadeo CS, Bussini S, Scarlato G. Interferon- inducible protein-10 is increased in the

cerebrospinal fluid of patients with multiple sclerosis. Journal of Neurology 246,

suppl.1: I/ 110, (1999). IX of the European Neurological Society, 5-9 June, 1999,

Milan, Italy.

Pagina 13 di 33


10. Prat E, Meda L, Galimberti D, Ardolino G, Agazzi P,Tadeo S, Baron PL, Scarpini E,

Conti G, Scarlato G. Amyloid peptides induce the production of MCP-1 in cultured

human astrocytes. Clinical Neuropathology 18: 150, (1999). XXXV Annual Meeting

of the Italian Neuropathological Association, May 27-29, 1999, Lipari, Italy.

11. Prat E, Baron PL, Meda L, Galimberti D, Livraghi S, Ardolino G, Clerici R, Scarpini

E, Scarlato G. Interferon-g-inducible protein-10 is increased in the cerebrospinal fluid

of patients with multiple sclerosis. Multiple Sclerosis 5 suppl 1: S83 (1999). Ectrims,

September 29 - October 3, 1999, Basel, Switzerland.

12. Scarpini E, Baron PL, Conti G, Bussini S, Galimberti D, Livraghi S, Scarlato G. Role

of proinflammatory cytokines in Schwann cells death. Atti Convegno, 140. Scientific

Convention Telethon, Rimini, 2000.

13. Scarpini E, Baron PL, Galimberti D, Prat E, Meda L, Ronzoni M, Siglienti I, Clerici R,

Conti G, Scarlato G. Serum and cerebrospinal fluid IP-10 as immunological marker in

multiple sclerosis. Neurology 56 (8), suppl.3: A366 (2001). 53th Meeting of the

American Academy of Neurology, May, 2001, Philadelphia, USA.

14. Conti G, De Pol A, Galimberti D, Scarpini E, Baron PL, Livraghi S, Scarlato G,

Rostami A. Expression of nitric oxide synthase during cell-mediated demyelination.

Clinical Neuropathology 20 (3): 118 (2001). XXXVII Annual Meeting of the Italian

Neuropathological Association, May 24-26, 2001, Verbania, Italy.

15. Galimberti D, Baron PL, Scarpini E, Prat E, Meda L, Ronzoni M, Siglienti I, Clerici R,

Conti G, Scarlato G. IP-10 and MCP-1 in serum and CSF: possible immunological

markers in multiple sclerosis. Clinical Neuropathology 20 (3): 122 (2001). XXXVII

Annual Meeting of the Italian Neuropathological Association, May 24-26, 2001,

Verbania, Italy.



markers in multiple sclerosis. Minerva Biotecnologica 13 (3): 191-192 (2001). XXIX

National Conference Italian Society of Immunology, June 6-9, 2001, Abano, Italy.



markers in multiple sclerosis. Journal of Neurology 248, suppl. 2: II/88 (2001). XI

Meeting of the European Neurological Society, April 21-25, 2001, Paris, France.

18. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P and the OMMAR Group.

Chemokine levels in CSF and serum from patients with different forms of dementia.

VII International Geneva/ Springfield Symposium on Advances in Alzheimer

Therapy. April 3-6, 2002.

19. Conti G, Pasquale C, Rostami A, De Pol A, Galimberti D, Scarpini E, Baron PL,

Scarlato G. Peripheral nervous system demyelination and iNOS expression. Journal of

Peripheral Nervous System 7 (1): 74, 2002.

20. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P and the DIACR Group.

Chemokine levels in CSF and serum from demented patients. Clinical

Neuropathology 21 (3): 118, 2002. XXXVIII Annual Meeting of the Italian

Neuropathological Association, May 2002, Napoli, Italy.

21. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P and the DIACR Group.

Chemokine levels in CSF and serum from patients with different types of dementia.

Journal of Neurology 249, suppl. 1: I/13-I14, 2002. XII Meeting of the European

Neurological Society, June 22-26, 2002, Berlin, Germany.

22. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P and the DIAR Group.

Chemokine levels in CSF and serum from patients with different types of dementia.

Neurobiology of Aging 23, suppl 1: S376-S377, 2002. VIII International Conference

on Alzheimer’s disease and related disorders. July 20-25, 2002, Stockholm, Sweden.

23. Fenoglio C, Galimberti D, Del Bo R, Corrà B, Guidi I, Tiriticco M, Cogiamanian F,

Scarpini E, Comi GP, Baron PL, Bresolin N, Scarlato G. Monocyte Chemotactic

Protein-1 gene (MCP-1) polymorphism in Alzheimer’s disease. Congresso ITINAD,

Sorrento, 18-19 Giugno 2002.

24. Fenoglio C, Galimberti D, Schoonenboom N, Scarpini E, Scheltens P and the DIAR

Group. Chemokine levels in CSF and serum from patients with different types of

Pagina 14 di 33


dementia. XIII Congresso Associazione Italiana di Neuroimmunologia, Moltrasio,

17-19 Ottobre 2002.

25. Gatti A, Fenoglio C, Galimberti D, Del Bo R, Corrà B, Guidi I, Tiriticco M,

Cogiamanian, F, Comi GP, Baron PL, Bresolin N, Scarpini E. Monocyte Chemotactic

Protein-1 (MCP-1) gene A-2518 polymorphism in Alzheimer’s disease. XIII

Congresso Associazione Italiana di Neuroimmunologia, Moltrasio, 17-19 Ottobre

2002.

26. Conti G, Rostami A, Scarpini E, Baron PL, Galimberti D, Scarlato G, Palumbo C, De

Pol A. Inducile Nitric Oxide Synthase (iNOS) expression during Experimental

Allergic Neuritis (EAN). Journal of Peripheral Nervous System 8 (1): 33, 2003.

27. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Perego L, Cogiamanian F,

Mariani C, Baron PL, Conti G, Bresolin N, Scarpini E. CC chemokine receptor gene

polymorphisms in patients with Alzheimer’s disease. VII Congresso ITINAD,

Sorrento, 22-24 Maggio 2003.

28. Fenoglio C, Galimberti D, Lovati C, Gatti A, Guidi I, Tiriticco M, Perego L, Mariani

C, Baron PL, Conti G, Bresolin N, Scarpini E. Monocyte chemotactic protein-1 gene

A-2518G polymorphism in Italian Alzheimer’s disease patients. VII Congresso

ITINAD, Sorrento, 22-24 Maggio 2003.

29. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Corrà B, Cogiamanian F, Baron

PL, Conti G, Mariani C, Bresolin N, Scarpini E. CCR2∆32 and CCR5-64I gene

polymorphisms in patients with Alzheimer’s disease. Clinical Neuropathology 22 (3):

148, 2003. XXXIX Annual Meeting of the Italian Neuropathological Association, June

9-12, 2003, Siena, Italy.

30. Fenoglio C, Galimberti D, Lovati C, Gatti A, Corrà B, Guidi I, Tiriticco M, Baron PL,

Conti G, Mariani C, Bresolin N, Scarpini E. A-2518G polymorphism of the chemokine

monocyte chemotactic protein-1 promoter in Alzheimer’s disease patients. Clinical

Neuropathology 22 (3): 146, 2003. XXXIX Annual Meeting of the Italian

Neuropathological Association, June 9-12, 2003, Siena, Italy.

31. Gatti A, Galimberti D, Fenoglio C, Del Bo R, Guidi I, Perego L, Cogiamanian F,

Tiriticco M, , Baron PL, Conti G, Comi GP, Bresolin N, Scarpini E. Alzheimer’s

disease: endothelial nitric oxide synthase gene polymorphism Glu298Asp and ApoE.

Clinical Neuropathology 22 (3): 149, 2003. XXXIX Annual Meeting of the Italian

Neuropathological Association, June 9-12, 2003, Siena, Italy.

32. Galimberti D, Fenoglio C, Lovati C, Gatti A, Corrà B, Guidi I, Cogiamanian F, Baron

PL, Conti G, Mariani C, Bresolin N, Scarpini E. CC chemokine receptor gene

polymorphisms in patients with Alzheimer’s disease. Journal of Neurology 250,

suppl. 2: II/13-II14, 2003. XIII Meeting of the European Neurological Society, June

14-18, 2003, Istanbul, Turkey.

33. Guidi I, Galimberti D, Fenoglio C, Del Bo R, Gatti A, Perego L, Cogiamanian F,

Tiriticco M, , Baron PL, Conti G, Comi GP, Bresolin N, Scarpini E. Endothelial nitric

oxide synthase gene polymorphism Glu298Asp and apolipoprotein E genotype in

Alzheimer’s disease. Journal of Neurology 250, suppl. 2: II/98, 2003. XIII Meeting

of the European Neurological Society, June 14-18, 2003, Istanbul, Turkey.

34. Fenoglio C, Galimberti D, Lovati C, Gatti A, Corrà B, Guidi I, Tiriticco M, Baron PL,

Conti G, Mariani C, Bresolin N, Scarpini. Monocyte chemotactic protein-1 gene A-

2518G polymorphism in Alzheimer’s disaease. Journal of Neurology 250, suppl. 2:

II/155, 2003. XIII Meeting of the European Neurological Society, June 14-18, 2003,

Istanbul, Turkey.

35. Fenoglio C, Galimberti D, Gatti A, Clerici R, Ronzoni M, De Riz M, Baron PL, Conti

G, Bresolin N, Scarpini E. E-selectin G98T single nucleotide polymorphism in patients

with Multiple Sclerosis. Multiple Sclerosis 9, Suppl. 1: S55, 2003. 19th Congress of

the European Committee for Treatment and Research in Multiple Sclerosis

(ECTRIMS), September 17-20, 2003, Milan, Italy.

36. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Cogiamanian F, Venturelli E,

Mariani C, Baron PL, Conti G, Bresolin N, Scarpini E. CCR2-64I and CCR5 gene

polymorphisms in patients with Alzheimer’s disease. Neurological Sciences 24,

Suppl.: S5, 2003. XXXIV Congress of the Italian Neurological Society, October 11-

15, 2003, Rome, Italy.

37. Guidi I, Galimberti D, Fenoglio C, Lovati C, Gatti A, Tiriticco M, Cogiamanian F,

Mariani C, Baron PL, Conti G, Bresolin N, Scarpini. Monocyte Chemotactic Protein-1

Pagina 15 di 33


gene A-2518G polymorphism in Italian Alzheimer’s disease patients. Neurological

Sciences 24, Suppl.: S80, 2003. XXXIV Congress of the Italian Neurological Society,

October 11-15, 2003, Rome, Italy.

38. Fenoglio C, Galimberti D, Gatti A, Clerici R, Ronzoni M, De Riz M, Venturelli E,

Baron PL, Conti G, Bresolin N, Scarpini E. E-selectin G98T single nucleotide

polymorphism in patients with Multiple Sclerosis. Neurological Sciences 24, Suppl.:

S162, 2003. XXXIV Congress of the Italian Neurological Society, October 11-15,

2003, Rome, Italy.

39. Fenoglio C, Galimberti D, Gatti A, Clerici R, Ronzoni M, De Riz M, Piccio L, Venturelli E, Constantin G, Baron PL, Conti G, Bresolin N, Scarpini E. E-selectin G98T and Ser128Arg single nucleotide polymorphisms in patients with Multiple Sclerosis. XIVCongresso Associazione Italiana di Neuroimmunologia, Taormina, 22-25 Ottobre 2003.

40. Gatti A, Galimberti D, Fenoglio C, Lovati C, Guidi I, Venturelli E, Fogliarino S,

Mailland E, Mariani C, Forloni G, Pettinati C, Baron PL, Conti G, Bresolin N, Scarpini E. CCR2-64I and CCR5delta32 gene polymorphisms in patients with Alzheimer’s disease. XIVCongresso Associazione Italiana di Neuroimmunologia, Taormina, 22-25 Ottobre 2003.

41. Venturelli E, Galimberti D, Del Bo R, Gatti A, Fenoglio C, Lovati C, Fogliarino

S, Como GP, Mariani C, Forloni G, Pettinati C, Baron PL, Conti G, Bresolin N, Scarpini E. Endothelial Nitric Oxide Synthase (e-NOS) gene polymorphism Glu298Asp and ApoE genotype in Alzheimer’s disease. XIVCongresso Associazione Italiana di Neuroimmunologia, Taormina, 22-25 Ottobre 2003.

42. Guidi I, Galimberti D, Venturelli E, Gatti A, Fenoglio C, Del Bo R, Lovati C, Galbiati

S, Comi GP, Mariani C, Forloni G, Baron PL, Conti G, Bresolin N, Scarpini E.

Glu298Asp polymorphism of the endothelial nitric oxide synthase (e-NOS) and

homocysteine levels in AD and VaD patients.VIII International Montreal/

Springfield Symposium on Advances in Alzheimer Therapy. Montreal, April 14-

17, 2004.

43. Fenoglio C, Galimberti D, Clerici R, Ronzoni M, De Riz M, Piccio L, Gatti A,

Venturelli E, Constantin G, Baron PL, Conti G, Bresolin N, Scarpini E. E-selectin

G98T and A561C single nucleotide polymorphisms in patients with multiple sclerosis.

Neurology 62 (7) suppl. 5: A274-275 (2004). 56th Meeting of the American Academy

of Neurology, S. Francisco, USA, April 24th-May 1st, 2004.

44. Gatti A, Galimberti D, Venturelli E, Guidi I, Fenoglio C, Lovati C, Mailland E, Alberti

G, Mariani C, Forloni G, Baron PL, Conti G, Bresolin N, Scarpini E. nNOS C276T

polymorphism in patients with Alzheimer’s disease. Clinical Neuropathology 23 (3):

126, 2004. 40th Annual Meeting of the Italian Neuropathological Association, May 24-

26, 2004, Padova, Italy.

45. Guidi I, Galimberti D, Lonati S, Novembrino C, Fenoglio C, Gatti A, Venturelli E,

Bamonti F, Baron PL, Conti G, Bresolin N, Scarpini E. Oxidative imbalance as

potential marker for Alzheimer’s disease. Clinical Neuropathology 23 (3): 127, 2004.

40 th Annual Meeting of the Italian Neuropathological Association, May 24-26, 2004,

Padova, Italy.

46. Venturelli E, Guidi I, Galimberti D, Gatti A, Fenoglio C, Del Bo R, Lovati C, Virgilio

R, Comi GP, Mariani C, Forloni G, Baron PL, Conti G, Bresolin N, Scarpini

E.Glu298Asp polymorphism of the e-NOS and homocysteine levels in patients with

Alzheimer’s disease. Clinical Neuropathology 23 (3): 137, 2004. 40th Annual

Meeting of the Italian Neuropathological Association, May 24-26, 2004, Padova, Italy.

47. Fenoglio C, Galimberti D, Clerici R, Ronzoni M, De Riz M, Piccio L, Rottoli MR,

Moroni S, Poloni M, Gatti A, Venturelli E, Baron PL, Conti G, Bresolin N, Scarpini E.

E-selectin G98T and A561C polymorphisms in patients with multiple sclerosis.

Clinical Neuropathology 23 (3): 123-124, 2004. 40th Annual Meeting of the Italian

Neuropathological Association, May 24-26, 2004, Padova, Italy.

48. Guidi I, Corrà B, Galimberti D, Lonati S, Novembrino C, Fenoglio C, Gatti A, Venturelli E, Bamonti F, Baron PL, Conti G, Bresolin N, Scarpini E. Il bilancio dei meccanismi ossido-reduttivi come potenziale marker nella malattia di Alzheimer. XLIV Congresso Nazionale della Società dei Neurologi, Neurochirurghi e Neuroradiologi Ospedalieri (S.N.O.), Vicenza, 26-29 Maggio

2004.

Pagina 16 di 33


49. Galimberti D, Guidi I, Lonati S, Novembrino C, Fenoglio C, Gatti A, Venturelli E,

Berti L, Bamonti F, , Baron PL, Conti G, Bresolin N, Scarpini E. Oxidative imbalance

as potential biological marker for Alzheimer’s disease. VIII Congresso ITINAD,


50. Venturelli E, Galimberti D, Guidi I, Lovati C, Del Bo R, Fenoglio C, Gatti A, Galbiati

S, Berti L, Comi GP, Mariani C, Forloni G, Bresolin N, Scarpini E. Influence of the

Glu/Glu genotype of the Glu298Asp polymorphism of NOS3 on age at onset and

plasma homocysteine levels. VIII Congresso ITINAD, Sorrento, 3-5 Giugno 2004.

51. Del Bo R, Virgilio R, Galbiati S, Grezzi S, Fenoglio C,Galimberti D, Galimberti G,

Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP. Polymorphism at codon 129

of the PRNP gene influences sporadic Alzheimer’s disease. VIII Congresso ITINAD,


52. Fenoglio C, Galimberti D, Clerici R, Ronzoni M, De Riz M, Piccio L, Rottoli M,

Moroni S, Gatti A, Venturelli E, Baron PL, Poloni M, Conti G, Bresolin N, Scarpini E.


Journal of Neurology 251, suppl. 3: III/25, 2004. XIV Meeting of the European

Neurological Society, June 26-30, 2004, Barcelona, Spain.



potential early marker for Alzheimer’s disease. Journal of Neurology 251, suppl. 3:

III/38, 2004. XIV Meeting of the European Neurological Society, June 26-30, 2004,

Barcelona, Spain.

54. Galimberti D, Guidi I, Venturelli E, Gatti A, Fenoglio C, del Bo R, Lovati C, Galbiati


Glu298Asp polymorphism of the e-NOS and homocysteine levels in patients with

Alzheimer’s disease and vascular dementia. Journal of Neurology 251, suppl. 3:

III/99, 2004. XIV Meeting of the European Neurological Society, June 26-30, 2004,

Barcelona, Spain.

55. Gatti A, Galimberti D, Venturelli E, Guidi I, Fenoglio C, Lovati C, Mailland E, Alberti

C, Mariani C, Forloni G, Baron PL, Conti G, Bresolin N, Scarpini E. n-NOS C276T

polymorphism in patients with Alzheimer’s disease . Journal of Neurology 251,

suppl. 3: III/100, 2004. XIV Meeting of the European Neurological Society, June 26-

30, 2004, Barcelona, Spain.

56. Galimberti D, Guidi I, Venturelli E, Gatti A, Fenoglio C, Del Bo R, Lovati C, Galbiati


Glu298Asp polymorphism of the eNOS gene and homocysteine levels in patients with

Alzheimer’s disease and vascular dementia. Neurobiology of Aging 25, suppl 2: S492,

2004. IX International Conference on Alzheimer’s disease and related disorders. July

17-22, 2004, Philadelphia, Pennsylvania, U.S.A.



potential biological marker for Alzheimer’s disease. Neurobiology of Aging 25, suppl

2: S358, 2004. IX International Conference on Alzheimer’s disease and related

disorders. July 17-22, 2004, Philadelphia, Pennsylvania, U.S.A.

58. R. Clerici, D. Galimberti, C. Fenoglio, M. De Riz, M. Ronzoni, L. Piccio, M. Rottoli,

M. Poloni, E. Venturelli, L. Berti, G. Constantin, N. Bresolin, E. Scarpini. E-selectin

G98T and A561C gene polymorphisms: association with multiple sclerosis and

correlation with clinical parameters. Neurological Sciences 25, Suppl.: S2, 2004.

XXXV Congress of the Italian Neurological Society, September 25-29, 2004, Genova,

Italy.

59. Galimberti D, Fenoglio C, Clerici R, Ronzoni M, De Riz M, Piccio L, Venturelli E,

Berti L, Constantin G, Bresolin N, Scarpini E. A novel SNP in the coding region of

PSGL-1 in multiple sclerosis patients. Neurological Sciences 25, Suppl.: S150, 2004.


Italy.

60. Mailland E, I. Guidi, Galimberti D, Lovati C, Bertora P, Venturelli E, Del Bo R,

Fenoglio C, Berti L, Dominici R, Pomati S, Clerici F, Comi GP, Bresolin N, Scarpini

E, Mariani C. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and

homocysteine levels in AD patients. Neurological Sciences 25, Suppl.: S184, 2004.

Pagina 17 di 33



Italy.

61. C. Lovati, I. Guidi, D. Galimberti, P. Bertora, E. Mailland, E. Venturelli, C. Fenoglio,

R. Dominaci, S. Pomati, F. Clerici, G. Alberti, L. Berti, N. Bresolin, E. Scarpini, C.

Mariani. Total Homocysteine levels in AD patients: analysis on different onset groups.

Neurological Sciences 25, Suppl.: S187, 2004. XXXV Congress of the Italian

Neurological Society, September 25-29, 2004, Genova, Italy.

62. I. Guidi, D. Galimberti, S. Lonati, C. Novembrino, C. Fenoglio, E. Venturelli, L. Berti,

F. Bamonti, N. Bresolin, E. Scarpini. Oxidative imbalance as potential biological

marker for Alzheimer’s disease. Neurological Sciences 25, Suppl.: S190, 2004.


Italy.

63. C. Fenoglio, D. Galimberti, R. Clerici, M. Ronzoni, M. De Riz, L. Piccio, A. Gatti, E.

Venturelli, L. Berti, G. Constantin, N. Bresolin, E. Scarpini. A novel SNP in the

coding region of PSGL-1 in multiple sclerosis patients. Journal of

Neuroimmunology 2004; 54(1-2): 24. 7th International Congress of

Neuroimmunology, September 28- October 2nd, 2004, Venice , Italy.

64. A. Gatti, D. Galimberti, C. Fenoglio, R. Clerici, M. De Riz, M. Ronzoni, L. Piccio, M.

Rottoli, S. Moroni, M. Poloni, E. Venturelli, L. Berti, G. Constantin, N. Bresolin, E.

Scarpini. E-selectin G98T and A561C polymorphisms in patients with multiple

sclerosis. Journal of Neuroimmunology 2004; 54(1-2): 25. 7th International Congress

of Neuroimmunology, September 28- October 2nd, 2004, Venice , Italy.

65. D. Galimberti, C. Fenoglio, R. Clerici, M. De Riz, M. Ronzoni, L. Piccio, M. Rottoli,

M. Poloni, E. Venturelli, L. Berti, G. Constantin, N. Bresolin, E. Scarpini. E-selectin

G98T and A561C gene polymorphisms: association with multiple sclerosis and

correlation with clinical parameters. Multiple Sclerosis 10, Suppl. 2: S208, 2004. 20th

Congress of the European Committee for Treatment and Research in Multiple

Sclerosis (ECTRIMS), October 6-9, 2004, Vienna, Austria.

66. C. Fenoglio, D. Galimberti, R. Clerici, M. Ronzoni, M. De Riz, L. Piccio, E.

Venturelli, L. Berti, G. Constantin, N. Bresolin, E. Scarpini. A novel SNP in the

coding region of PSGL-1 in multiple sclerosis patients. Multiple Sclerosis 10, Suppl.

2: S211, 2004. 20th Congress of the European Committee for Treatment and Research

in Multiple Sclerosis (ECTRIMS), October 6-9, 2004, Vienna, Austria.

67. D. Galimberti, C. Fenoglio, M. De Riz, M. Ronzoni, L. Piccio, C. Comi, E. Venturelli,

E. Brighina, D. Scalabrini, F. Monaco, G. Constantin, N. Bresolin, E. Scarpini.

Influence of the novel M62I polymorphism in PSGL-1 gene on susceptibility and

progression of Multiple Sclerosis. Neurology 64 (6) suppl. 1: A86 (2005). 57th

Meeting of the American Academy of Neurology, Miami, USA, April 9th-16th, 2005.

68. R. Del Bo, M. Scarlato, S. Ghezzi, F. Martinelli-Boneschi, C. Fenoglio, S. Galbiati, R.

Virgilio, D. Galimberti, G. Galimberti, M. Crimi, C. Ferrarese, E. Scarpini, N.

Bresolin, GP. Comi. Association between VEGF gene and sporadic Alzheimer’s

disease. Neurology 64 (6) suppl. 1: A415 (2005). 57th Meeting of the American

Academy of Neurology, Miami, USA, April 9th-16th, 2005.

69. M. Poli, L. Benerini, C. Lovati, C. Mariani, D. Galimberti, E. Scarpini, I. Biunno, A.

Albertini, R. Dominici, D. Finazzi. The C+651T>G polymorphism in Aph-1b is

associated with Alzheimer’s disease. Second Meeting on the Molecular Mechanisms

of Neurodegeneration, Milan, Italy, 7-10 May 2005.

70. R. Del Bo, M. Scarlato, S. Ghezzi, F. Martinelli-Boneschi, C. Fenoglio, S. Galbiati, R.

Virgilio, D. Galimberti, G. Galimberti, M. Crimi, C. Ferrarese, E. Scarpini, N.

Bresolin, GP. Comi. Association between VEGF gene and sporadic Alzheimer’s

disease. Second Meeting on the Molecular Mechanisms of Neurodegeneration, Milan,

Italy, 7-10 May 2005.

71. D. Albani, S. Batelli, M. Pesaresi, F. Prato, D. Galimberti, V. Artuso, I. Roiter, E.

Scarpini, G. Forloni. A possible association between the presenilin-1 substitution

glu318gly and familiar Alzheimer’s disease in the Italian population. Clinical

Neuropathology 24 (3): 133, 2005. 41st Annual Meeting of the Italian Association of

Neuropathology (AINP) jointly with the French Society of Neuropathology – 31st

Meeting of the Italian Association for Research on Brain Aging (AIRIC), May 26-28,

2005, Saluzzo, Italy.

Pagina 18 di 33


72. D. Galimberti, N. Schoonenboom, E. Venturelli, C. Fenoglio, N. Bresolin, P.

Scheltens, E. Scarpini. CSF chemokine levels: differences among MCI, AD and FTLD

patients. Implication in AD pathogenesis and possible relevance for early diagnosis.

Clinical Neuropathology 24 (3): 141, 2005. 41st Annual Meeting of the Italian

Association of Neuropathology (AINP) jointly with the French Society of

Neuropathology – 31st Meeting of the Italian Association for Research on Brain Aging

(AIRIC), May 26-28, 2005, Saluzzo, Italy.

73. M. Pesaresi, C. Lovati, P. Bertora, E. Mailland, R. Dominici, F. Clerici, C. Mariani, D.

Galimberti, E. Scarpini, PL. Quadri, G. Forloni. Decreased plasma levels of amyloid

in Alzheimer (AD) patients. Clinical Neuropathology 24 (3): 147, 2005. 41st Annual

Meeting of the Italian Association of Neuropathology (AINP) jointly with the French

Society of Neuropathology – 31st Meeting of the Italian Association for Research on

Brain Aging (AIRIC), May 26-28, 2005, Saluzzo, Italy.

74. E. Venturelli, D. Galimberti, C. Lovati, C. Fenoglio, D. Scalabrini, C. Mariani, G.

Forloni, N. Bresolin, E. Scarpini. The T-786C NOS3 polymorphism in Alzheimer’s

disease: association and transcriptional analysis. Clinical Neuropathology 24 (3):

152, 2005. 41st Annual Meeting of the Italian Association of Neuropathology (AINP)

jointly with the French Society of Neuropathology – 31st Meeting of the Italian

Association for Research on Brain Aging (AIRIC), May 26-28, 2005, Saluzzo, Italy.

75. M. Giunta, AE. Rigamonti, E. Scarpini, D. Galimberti, SM. Bonomo, EE Muller, SG. Cella. The leukocyte expression of CD36 is reduced in patients with Alzheimer’s disease and in early phase of dementia. Clinical Neuropathology 24 (3): 141, 2005. 41

st Annual Meeting of the Italian Association of

Neuropathology (AINP) jointly with the French Society of Neuropathology – 31

st Meeting of the Italian Association for Research on Brain Aging (AIRIC),

May 26-28, 2005, Saluzzo, Italy.

76. D. Galimberti, N. Schoonenboom, P. Scheltens, C. fenoglio, E. Venturelli, D. Scalabrini, N. Bresolin, E. Scarpini. CSF chemokine levels: differences among MCI, AD and FTLD patients. Implication in AD pathogenesis and possible relevance for early diagnosis. IX Congresso ITINAD, Sorrento, 26-28 Maggio

2005.

77. E. Venturelli, D. Galimberti, C. Lovati, C. Fenoglio, D. Scalabrini, C. Mariani, G.

Forloni, N. Bresolin, E. Scarpini. Te T-786C NOS3 polymorphism in Alzheimer’s disease: association and influence on gene expression. IX Congresso ITINAD, Sorrento, 26-28 Maggio 2005.

78. R. Del Bo, M. Scarlato, S. Ghezzi, F. Martinelli-Boneschi, C. Fenoglio, S.

Galbiati, R. Virgilio, D. Galimberti, G. Galimberti, C. Ferrarese, E. Scarpini, N. Bresolin, GP. Comi. VEGF is a novel susceptibility gene for sporadic Alzheimer’s disease. IX Congresso ITINAD, Sorrento, 26-28 Maggio 2005.

79. Venturelli E, Galimberti D, Lovati C, Fenoglio C, Scalabrini D, Mariani C,

Forloni G, Bresolin N, Scarpini E. The T-786C polymorphism in Alzheimer’s disease: association and influence on gene expression. Journal of Neurology 252, suppl. 2: II/107, 2005. XV Meeting of the European Neurological Society, June

18-22, 2005, Vienna, Austria.

80. Fenoglio C, Galimberti D, Bam M, Maranian M, Yeo TW, De Riz M, Ronzoni M,

Scalabrini D, Venturelli E, Piccio L, Bresolin N, Scarpini E, Compston A, Sawcer S.

P-selectin (SELP) and P-selectin glicoprotein ligand-1 (SELPLG) polymorphisms in

multiple sclerosis patients. Journal of Neurology 252, suppl. 2: II/21-22, 2005. XV

Meeting of the European Neurological Society, June 18-22, 2005, Vienna, Austria.

81. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Bresolin N,

Scarpini E. CSF chemokine levels: differences among MCI, AD and FTLD patients.

Implication in AD pathogenesis and possible relevance for early diagnosis. Journal of

Neurology 252, suppl. 2: II/125, 2005. XV Meeting of the European Neurological

Society, June 18-22, 2005, Vienna, Austria.

82. Guidi I, Cornelli U, Novembrino C, Lonati S, Galimberti D, Scarpini E,

Lambertenghi-Deliliers G, Bamonti F. Clinical chemistry 51: suppl. 6(2005): A119.

83. Fenoglio C, Galimberti D, Bam M, Maranian M, Scalabrini D, Venturelli E, Piccio L,

De Riz M, Yeo TW, Goris A, Grey G, Bresolin N, Scarpini E, Compston A, Sawcer S.

SELP and SELPLG single nucleotide polymorphisms in multiple sclerosis. Multiple

Pagina 19 di 33


Sclerosis 2005; 11, Suppl. 1: S118. 21th Congress of the European Committee for

Treatment and Research in Multiple Sclerosis (ECTRIMS), September 28-October 1,

2005, Thessaloniki, Greece.

84. Galimberti D, Scalabrini D, Fenoglio C, Como C, De Riz M, Venturelli E, Castelli L,

Piccio L, Ronzoni M, Brighina E, Lovati C, Mariani C, Monaco F, Bresolin N,

Scarpini E. P-selectin glycoprotein ligand-1 variable number of tandem repeats

(VNTR) polymorphism in patients with multiple sclerosis. Multiple Sclerosis 2005;

11, Suppl. 1: S118. 21th Congress of the European Committee for Treatment and

Research in Multiple Sclerosis (ECTRIMS), September 28-October 1, 2005,

Thessaloniki, Greece.

85. Scarpini E, Galimberti D, Schoonenboom N, Fenoglio C, Venturelli E, Bresolin N,

Scheltens P. Increased intrathecal chemokine synthesis in MCI and mild AD patients.

Inmplications in the pathogenesis and re0levance for early diagnosis. Neurological

Sciences 26, Suppl.: S76, 2005. XXXVI Congress of the Italian Neurological Society,

October 8-12, 2005, Cernobbio, Italy.

86. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Castelli L,

Piccio L, Ronzoni M, Brighina E, Lovati C, Mariani C, Monaco F, Bresolin N,

Scarpini E. P-selectin glycoprotein ligand-1 variable number of tandem repeats

(VNTR) polymorphism in patients with multiple sclerosis. Neurological Sciences 26,

Suppl.: S171, 2005. XXXVI Congress of the Italian Neurological Society, October 8-

12, 2005, Cernobbio, Italy.

87. Fenoglio C, Galimberti D, Ban M, Maranian M, Scalabrini D, Venturelli E, Piccio L,

De Riz M, Yeo TW, Goris A, Grey J, Bresolin N, Scarpini E, Compston A, Sawcer S.

SELPLG and SELP single nucleotide polymorphisms in multiple sclerosis.

Neurological Sciences 26, Suppl.: S272, 2005. XXXVI Congress of the Italian

Neurological Society, October 8-12, 2005, Cernobbio, Italy.

88. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E,

Blankenstein MA, Bresolin N, Scarpini E. Sintesi intratecale di chemochine nel

decadimento cognitivo lieve e nella malattia di Alzheimer. 3rd Annual Meeting on

Brain Aging and Dementia. Brescia, 1-3 Dicembre 2005.

89. Scarpini E, Galimberti D, Schoonenboom N, Fenoglio C, Venturelli E,

Pijnenburg YAL, Bresolin N, Scheltens P. Intrathecal chemochine levels in cortical lobar degenerations. 3rd Annual Meeting on Brain Aging and Dementia. Brescia, 1-3 Dicembre 2005.

90. E. Scarpini, D. Galimberti, N. Bresolin. Genetics and neurobiology of Frontotemporal

Lobar Degeneration. Neurological Sciences 2006;27 Suppl.1: S32-S34. XV Riunione

Annuale SIN-SNO, 17-18 Marzo 2006, Varese.


Blankenstein MA, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in mild

cognitive impairment and Alzheimer’s disease. Neurology 66 (5) suppl. 2: A281

(2006). 58th Meeting of the American Academy of Neurology, San Diego, USA, April

1st-8th, 2006.


Blankenstein M, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in mild

cognitive impairment and Alzheimer disease. IX International Montreal/

Springfield Symposium on Advances in Alzheimer Therapy. Geneva, April 19-22,

2006.

93. Albani D, Batelli S, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A,

Franceschi M, Roiter I, Artuso V, Forloni G. Presenelin-1 mutation E318G in the

Italian population. Clinical Neuropathology 25(3): 134 (2006). 42nd Annual Meeting

of the Italian Association of Neuropathology (AINP) – 32nd Meeting of the Italian

Association for Resesrch on Brain Aging (AIRIC), May 24-27, 2006, Rome Italy.

94. Fenoglio C, Galimberti D, Venturelli E, Piccio L, Scalabrini D, Panina P, Buonsanti C,

Lovati C, Baron P, Forloni G, Mariani C, Bresolin N, Scarpini E. Absence of mutation

in TREM-2 coding region in early-onset dementia. Clinical Neuropathology 25(3):

143 (2006). 42nd Annual Meeting of the Italian Association of Neuropathology

(AINP) – 32nd Meeting of the Italian Association for Resesrch on Brain Aging

(AIRIC), May 24-27, 2006, Rome Italy.


Pagina 20 di 33


Clerici F, Mariani C, Bresolin N, Scarpini E. Chemokine serum levels in mild

cognitive impairment and Alzheimer’s disease. Clinical Neuropathology 25(3): 145

(2006). 42nd Annual Meeting of the Italian Association of Neuropathology (AINP) –

32nd Meeting of the Italian Association for Resesrch on Brain Aging (AIRIC), May

24-27, 2006, Rome Italy.

96. Prato F, Albani D, Galimberti D, Fenoglio C, Scarpini E, Forloni G. Genetic analysis

of the 5HTTLPR polymorphism in Alzheimer’s disease and frontotemporal dementia.

Clinical Neuropathology 25(3): 154 (2006). 42nd Annual Meeting of the Italian

Association of Neuropathology (AINP) – 32nd Meeting of the Italian Association for

Resesrch on Brain Aging (AIRIC), May 24-27, 2006, Rome Italy.



cognitive impairment and Alzheimer’s disease. Journal of Neurology 253, suppl. 2:

II/40, 2006. XVI Meeting of the European Neurological Society, May 27-31, 2006,

Lausanne, Switzerland.

98. Venturelli E, Fenoglio C, Galimberti D, Piccio L, Scalabrini D, Panina P, Buonsanti C,

Lovati C, Baron P, Forloni G, Mariani C, Bresolin N, Scarpini E. Absence of

mutations in TREM-2 coding region in patients with early onset dementia. Journal of

Neurology 253, suppl. 2: II/51-52, 2006. XVI Meeting of the European Neurological

Society, May 27-31, 2006, Lausanne, Switzerland.

99. Fenoglio C, Galimberti D, Scalabrini D, Comi C, De Riz M, Venturelli E, Lovati C,

Brighina E, Mariani C, Monaco F, Bresolin N, Scarpini E. Haplotypes in IP-10 gene

and multiple sclerosis: association and correlation with clinical course. Journal of

Neurology 253, suppl. 2: II/59, 2006. XVI Meeting of the European Neurological

Society, May 27-31, 2006, Lausanne, Switzerland.

100. Corrà B, Galimberti D, Guidi I, Tiriticco M, Perego L, Dobrea A, Baron P, Bresolin N,

Scarpini E. Efficacy of low-dose memantine in reducing behavioural symptoms in AD

patients. Journal of Neurology 253, suppl. 2: II/89-90, 2006. XVI Meeting of the

European Neurological Society, May 27-31, 2006, Lausanne, Switzerland.

101. Guidi I, Galimberti D, Dobrea A, Corrà B, Tiriticco M, Perego L, Bonino F, Bresolin

N, Scarpini E. Association between dementia and cancer. Journal of Neurology 253,

suppl. 2: II/92, 2006. XVI Meeting of the European Neurological Society, May 27-31,

2006, Lausanne, Switzerland.



mutations in TREM-2 coding region in early onset dementia. X Congresso ITINAD,

Roma, 8-10 Giugno 2006.



cognitive impairment and Alzheimer’s disease. X Congresso ITINAD, Roma, 8-10

Giugno 2006.

104. Poli M, Benerini Gatta L, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I,

Musicco M, Finazzi D. Genetic and biological characterization of Aph-1B C+651T>G

(F217L) polymorphism. X Congresso ITINAD, Roma, 8-10 Giugno 2006.


Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in

mild cognitive impairment and Alzheimer’s disease. II Nubin Symposium on

biomarkers for inflammation and neurodegeneration in body fluids. June 19-20, 2006,

Amsteradam, The Netherlands.

106. Lovati C, Bertora P, Galimberti D, Suardelli M, Mailland E, Rosa S, Capiluppi E,

Vanotti A, Pomati S, Mariani C. Total folate levels in Alzheimer disease and other

forms of degenerative cognitive decline. Alzheimer’s & Dementia 2(3), suppl 1:

S147-148, 2006. X International Conference on Alzheimer’s disease and related

disorders. July 15-20, 2006, Madrid, Spain.

107. Guidi I, Galimberti D, Dobrea A, Corrà B, Tiriticco M, Perego L, Bonino F, Bresolin

N, Scarpini E. Association between dementia and cancer. Alzheimer’s & Dementia

2(3), suppl 1: S161, 2006. X International Conference on Alzheimer’s disease and

related disorders. July 15-20, 2006, Madrid, Spain.

Pagina 21 di 33


108. Forloni G, Batelli S, Prati F, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A,

Franceschi M, Roiter I, Artuso V, Albani D. Presenilin-1 mutation E318G in Italian

population: genetic screening and effect on beta amyloid metabolism in human

fibroblasts. Alzheimer’s & Dementia 2(3), suppl 1: S193-194, 2006. X International

Conference on Alzheimer’s disease and related disorders. July 15-20, 2006, Madrid,

Spain.

109. Corrà B, Galimberti D, Guidi I, Tiriticco M, Perego L, Dobrea A, Bresolin N, Scarpini

E. Low doses of memantine are effective in reducing behavioral symptoms in AD

patients. Alzheimer’s & Dementia 2(3), suppl 1: S228, 2006. X International

Conference on Alzheimer’s disease and related disorders. July 15-20, 2006, Madrid,

Spain.



cognitive impairment as Alzheimer’s disease early biomarkers. Alzheimer’s &

Dementia 2(3), suppl 1: S274, 2006. X International Conference on Alzheimer’s

disease and related disorders. July 15-20, 2006, Madrid, Spain.



mutations in TREM-2 coding region in early onset dementia. Alzheimer’s &

Dementia 2(3), suppl 1: S423, 2006. X International Conference on Alzheimer’s

disease and related disorders. July 15-20, 2006, Madrid, Spain.



cognitive impairment as Alzheimer’s disease early biomarkers. European Journal of

Neurology 2006; 13 Suppl. 2: 31-32. 10th Congress of the European Federation of

Neurological Societies, September 2-5, 2006, Glasgow, UK.

113. Pomati S, Bertora P, Borgo F, Bortolami C, Brambilla A, Di Maio S, Galimberti D,

Gornati R, Lovati C, Osio M, Pelucchi A, Pisacreta M, Porretta T, Suardelli M,

Mariani C. Carotid endarterectomy and cognitive functions in patients without

cognitive impairment at baseline: a longitudinal study. European Journal of

Neurology 2006; 13 Suppl. 2: 44. 10th Congress of the European Federation of

Neurological Societies, September 2-5, 2006, Glasgow, UK.

114. Lovati C, Bertora P, Pesaresi M, Galimberti D, Venturelli E, Mailland E, Rosa S,

Clerici F, Pomati S, Scarpini E, Forloni G, Mariani C. Plasma levels of beta-amyloid

(1-42) in fronto-temporal dementia. European Journal of Neurology 2006; 13 Suppl.

2: 68. 10th Congress of the European Federation of Neurological Societies, September

2-5, 2006, Glasgow, UK.

115. Comi C, Castelli L, Ciocchetti A, Galimberti D, Fenoglio C, Mesturini R, Cappellano

G, Cerutti E, Carecchio M, Leone M, Perla F, Scarpini E, Monaco F, Dianzani U.

ICOS gene haplotypes correlate with multiple sclerosis development and progression.

Multiple Sclerosis 2006; 12, Suppl. 1: S58. 22th Congress of the European Committee

for Treatment and Research in Multiple Sclerosis (ECTRIMS), September 27-30,

2006, Madrid, Spain.

116. Comi C, Cappellano G, Ciocchetti A, Galimberti D, Fenoglio C, Cerutti E, Castelli L,

Mesturini R, Carecchio M, Leone M, Scarpini E, Monaco F, Dianzani U. A91V

variation of the perforin gene in patients with multiple sclerosis. Multiple Sclerosis

2006; 12, Suppl. 1: S72. 22th Congress of the European Committee for Treatment and

Research in Multiple Sclerosis (ECTRIMS), September 27-30, 2006, Madrid, Spain.

117. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Brighina E,

Piola M, Cortini F, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E. IP-10

haplotypes and multiple sclerosis: association and correlation with clinical course.

Multiple Sclerosis 2006; 12, Suppl. 1: S73. 22th Congress of the European Committee

for Treatment and Research in Multiple Sclerosis (ECTRIMS), September 27-30,

2006, Madrid, Spain.

118. Lovati C, Suardelli M, Bertora P, Galimberti D, Pesaresi M, Rosa S, Pomati S,

Brambilla A, Scarpini E, Mariani C. Prevalence of ApoE-epsilon2 allele in different

kinds of neurodegenerative dementia. Neurological Sciences 27, Suppl.: S29, 2006.

XXXVII Congress of the Italian Neurological Society, October 14-18, 2006, Bari,

Italy.


Pagina 22 di 33


Cortini F, Clerici F, Mariani C, Bresolin N, Scarpini E. Chemokine serum levels in

mild cognitive impairment and Alzheimer’s disease. Neurological Sciences 27,

Suppl.: S31, 2006. XXXVII Congress of the Italian Neurological Society, October 14-

18, 2006, Bari, Italy.

120. Brighina E, Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E,

Piola M, Cortini F, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E. IP-10

haplotypes and multiple sclerosis: association and correlation with clinical course.

Neurological Sciences 27, Suppl.: S193, 2006. XXXVII Congress of the Italian

Neurological Society, October 14-18, 2006, Bari, Italy.

121. Comi C, Castelli L, Cerutti E, Ciocchetti A, Galimberti D, Fenoglio C, Cappellano G,

Calzoni S, Naldi P, Bonissoni S, Carecchio M, Collimedaglia L, Scarpini E, Monaco

F, Dianzani U. Two single-nucleotide polymorphisms in the 5’ and 3’ ends of the

osteopontin gene contribute to susceptibility to multiple sclerosis. Neurological

Sciences 27, Suppl.: S262, 2006. XXXVII Congress of the Italian Neurological

Society, October 14-18, 2006, Bari, Italy.

122. Bertora P, Lovati C, Pesaresi M, Venturelli E, Suardelli M, Galimberti D, Rosa S,

Brambilla A, Forloni G, Pomati S, Scarpini E, Mariani C. Plasma levels of beta-

amyloid (1-42) in frontotemporal dementia. Neurological Sciences 27, Suppl.: S276-

277, 2006. XXXVII Congress of the Italian Neurological Society, October 14-18,

2006, Bari, Italy.

123. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Lovati C,

Mariani C, Monaco F, Bresolin N, Scarpini E. CXCL10 haplotypes and multiple

sclerosis: association and correlation with clinical course. European Charcot

Foundation Symposium 2006, November 16-18, 2006, Taormina (Italy).

124. Lovati C, Bertora P, Galimberti D, Pesaresi M, Venturelli E, Prato F, Scarpini E,

Forloni G, Mariani C. Prevalence of ApoE-e2 allele in different kinds of dementia.

Neurology 68 (12) suppl. 1: A309 (2007). 59th Meeting of the American Academy of

Neurology, Boston, USA, April 28th-May 5th, 2007.

125. Galimberti D, Lovati C, Venturelli E, Bertora P, Guidi I, Fenoglio C, Cortini F,

Cislaghi G, Clerici F, Forloni G, Bresolin N, Mariani C, Scarpini E. ApoE e2

decreases the susceptibility to develop Alzheimer’s disease but not frontotemporal

lobar degeneration, Lewy body disease or vascular dementia. Journal of Neurology

254, suppl. 3: III/11, 2007. XVII Meeting of the European Neurological Society, June

16-20, 2007, Rhodes, Greece.

126. Guidi I, Galimberti D, Fenoglio C, Venturelli E, Perego L, Bresolin N, Scarpini E.

CSF biomarkers and APOE4 in MCI, AD and related disorders: usefulness for

diagnosis and correlation with clinical phenotypes. Journal of Neurology 254, suppl.

3: III/43, 2007. XVII Meeting of the European Neurological Society, June 16-20,

2007, Rhodes, Greece.

127. Fenoglio C, Galimberti D, Cortini F, Venturelli E, Scalabrini D, Guidi I, Villa C, Del

Bo R, Lovati C, Mariani C, Bresolin N, Scarpini E. Progranulin gene mutation

scanning in Italian Alzheimer’s disease population. Journal of Neurology 254, suppl.

3: III/43-44, 2007. XVII Meeting of the European Neurological Society, June 16-20,

2007, Rhodes, Greece.

128. Scalabrino G, Galimberti D, Scalabrini D, Bamonti F, Veber D, Mutti E, Carpo M, De

Riz M, Capra R, Cordioli C, Scarpini E. Changes in vitamin B12 and tumor necrosis

factor- levels in cerebrospinal fluid of patients with different subtypes of multiple

sclerosis. Journal of Neurology 254, suppl. 3: III/133, 2007. XVII Meeting of the

European Neurological Society, June 16-20, 2007, Rhodes, Greece.

129. De Riz M, Galimberti D, Scalabrini D, Fenoglio C, Comi C, Venturelli E, Cortini F,

Piola M, Brighina E, Dianzani U, D’Alfonso S, Monaco F, Bresolin N, Scarpini E.

Gender-specific influence of the chromosome 16 gene cluster on the susceptibility to

multiple sclerosis. Journal of Neurology 254, suppl. 3: III/133, 2007. XVII Meeting

of the European Neurological Society, June 16-20, 2007, Rhodes, Greece.

130. Cortini F, Fenoglio C, Scarpini E, Scalabrini D, Venturelli E, Guidi I, Villa C, Lovati

C, Mariani C, Forloni G, Bresolin N, Galimberti D. PGRN polymorphisms influence

the susceptibility for Alzheimer’s disease. Clinical Neuropathology 26(5): 248-249

(2007). 43rd Annual Meeting of the Italian Association of Neuropathology (AINP) –

XXXIII Meeting of the Italian Association for Resesrch on Brain Aging (AIRIC),

September 30-October 3, 2007, Verona, Italy.

Pagina 23 di 33


131. Scalabrini D, Galimberti D, Fenoglio C, De Riz M, Comi C, Venturelli E, Cortini F,

Piola M, Dianzani U, Leone M, Monaco F, Bresolin N, Scarpini E. Gender-specific

influence of the chromosome 16 chemokine gene cluster on the susceptibility to

multiple sclerosis. Clinical Neuropathology 26(5): 259 (2007). 43rd Annual Meeting

of the Italian Association of Neuropathology (AINP) – XXXIII Meeting of the Italian

Association for Resesrch on Brain Aging (AIRIC), September 30-October 3, 2007,

Verona, Italy.

132. Venturelli E, Galimberti D, Fenoglio C, Guidi I, Villa C, Bergamaschini L, Cortini F,

Scalabrini D, Baron P, Vergani C, Bresolin N, Scarpini E. CSF levels of IL-6, IL-11,

LIF, A42, TAU and phospoTAU biomarkers in Alzheimer’s disease and

Frontotemporal Lobar Degeneration. Clinical Neuropathology 26(5): 261 (2007).

43rd Annual Meeting of the Italian Association of Neuropathology (AINP) – XXXIII

Meeting of the Italian Association for Resesrch on Brain Aging (AIRIC), September

30-October 3, 2007, Verona, Italy.

133. Villa C, Venturelli E, Scarpini E, Fenoglio C, Guidi I, Lovati C, Marcone A, Cortini F,

Scalabrini D, Clerici F, Bresolin N, Mariani C, Cappa S, Galimberti D. Neuronal nitric

oxide synthase C276T polymorphism increases the risk for Frontotemporal Lobar

Degeneration. Clinical Neuropathology 26(5): 248-249 (2007). 43rd Annual Meeting

of the Italian Association of Neuropathology (AINP) – XXXIII Meeting of the Italian

Association for Research on Brain Aging (AIRIC), September 30-October 3, 2007,

Verona, Italy.

134. Benerini Gatta L, Galimberti D, Venturelli E, Scarpini E, Lovati C, Mariani C, Finazzi

D. The locus 387715 in Alzheimer’s disease. XI Congresso ITINAD, Olbia, 4-6

Ottobre 2007.

135. Fenoglio C, Galimberti D, Cortini F, Scalabrini D, Venturelli E, Guidi I, Villa C, Del

Bo R, Lovati C, Mariani C, Bresolin N, Scarpini E. Progranulin gene variations

associated with Alzheimer’s disease. XI Congresso ITINAD, Olbia, 4-6 Ottobre 2007.

136. Galimberti D, Venturelli E, Villa C, Fenoglio C, Guidi I, Lovati C, Marcone A,

Cortini F, Scalabrini D, Clerici F, Bresolin N, Mariani C, Cappa S, Scarpini E. Neuronal Nitric Oxide Synthase C276T polymorphism increases the risk for Frontotemporal Lobar Degeneration. XI Congresso ITINAD, Olbia, 4-6 Ottobre

2007.

137. Piccio L, Buonsanti C, Cella M, Rinker J, Fenoglio C, Galimberti D, Scarpini E,

Panina-Bordignon P, Colonna M, Cross AH. Expression of a membrane-bound and

solubile form of TREM-2 in the central nervous system: association with multiple

sclerosis. Multiple Sclerosis 2007; 13, Suppl. 2: S156. 23rd Congress of the European

Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), October

11-14, 2007, Prague, Czech Republic.

138. Comi C, Castelli L, Cerutti E, Chiocchetti A, Galimberti D, Fenoglio C, Cappellano G,

Calzoni S, Naldi P, Bonissoni S, Carecchio M, Nasuelli N, Scarpini E, Monaco F,

Dianzani U. Osteopontin gene variations protect against multiple sclerosis

development and evolution. Multiple Sclerosis 2007; 13, Suppl. 2: S194. 23rd


Sclerosis (ECTRIMS), October 11-14, 2007, Prague, Czech Republic.

139. Fenoglio C, Galimberti D, Scalabrini D, De Riz M, Comi C, Venturelli E, Cortini

F, Piola M, Bresolin N, Scarpini E, Dianzani U, D’Alfonso S, Leone M, Monaco F. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis. Multiple Sclerosis 2007; 13, Suppl. 2:

S202. 23rd Congress of the European Committee for Treatment and Research in

Multiple Sclerosis (ECTRIMS), October 11-14, 2007, Prague, Czech Republic.

140. Fenoglio C, Piccio L, Cross AH, Scalabrini D, Piola M, De Riz M, Venturelli E,

Cortini F, Villa C, Parks B, Rinker J, Bresolin N, Scarpini E, Galimberti D. Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. Multiple Sclerosis 2007; 13, Suppl. 2: S272. 23rd


Sclerosis (ECTRIMS), October 11-14, 2007, Prague, Czech Republic.

141. Galimberti D, Lovati C, Bertora P, Venturelli E, Cislaghi G, Guidi I, Fenoglio C,

Cortini F, Clerici F, Finazzi D, Albani D, Forloni G, Bresolin N, Mariani C, Scarpini

E. ApoE e2 and e4 influence the susceptibility for Alzheimer’s disease but not other

dementias. Neurological Sciences 28, Suppl.: S92, 2007. XXXVIII Congress of the

Pagina 24 di 33


Italian Neurological Society, October 13-17, 2007, Firenze, Italy.

142. Galimberti D, Venturelli E, Fenoglio C, Guidi I, Villa C, Bergamaschini L, Cortini F, Scalabrini D, Baron P, Vergani C, Bresolin N, Scarpini E. Intrathecal levels

of IL-6, IL-11, LIF, and A42, tau and phosphotau biomarkers in Alzheimer’s disease and Frontotemporal Lobar Degeneration. Neurological Sciences 28,

Suppl.: S93, 2007. XXXVIII Congress of the Italian Neurological Society, October 13-

17, 2007, Firenze, Italy.

143. Galimberti D, Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E, Cortini

F, Piola M, Dianzani U, D’Alfonso S, Leone M, Monaco F, Bresolin N, Scarpini E. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis. Neurological Sciences 28, Suppl.: S197-

198, 2007. XXXVIII Congress of the Italian Neurological Society, October 13-17,

2007, Firenze, Italy.

144. Comi C, Nicola S, Galimberti D, Carecchio M, Ciocchetti A, Fenoglio C,

Cappellano G, Scarpini E, Monaco F, Dianzani U. High levels of osteopontin in the CSF of patients with Alzheimer’s disease. Neurological Sciences 28, Suppl.:

S373, 2007. XXXVIII Congress of the Italian Neurological Society, October 13-17,


145. Sansone V, Gandossini S, Galimberti D, Fenoglio C, Cotelli M, Calabria M, Scarpini

E, Meola G. Cerebrospinal fluid (CSF) Tau and amyloid Bbta42 (A42) protein

abnormalities correlate with executive dysfuction in Myotonic Dystrophy Type 1

(DM1) and Type 2 (DM2). Neurology 70:Suppl 1(2008): P06.023 (A306). 60th

American Academy of Neurology (AAN), Chicago, April 2008.

146. Galimberti D, Fenoglio C, Cortini F, Venturelli E, Scalabrini D, Villa C, Guidi I,

Dalla Valle E, Lovati C, Mariani C, Bresolin N, Scarpini E. Progranulin gene mutation scanning and expression analysis in patients with Alzheimer’s disease. Neurology 70:Suppl 1(2008): S21.005 (A226). 60th American

Academy of Neurology (AAN), Chicago, April 2008.

147. Scarpini E, Galimberti D. Behavioural disturbances in frontotemporal lobar

degeneration: recent advances in molecular genetics and neurobiology. Journal of

Neurology 255, Suppl. 2: 4-5 (2008). XVIII Meeting of the European Neurological

Society, June 7-11, 2008, Nice, France.

148. Fenoglio C, Galimberti D, Cortini F, Kauwe JSK, Venturelli E, Guidi I, Scalabrini D,

Villa C, Mayo K, Dalla Valle E, Lovati C, Mariani C, Bresolin N, Goate AM, Scarpini

E. Genetic and functional analysis of progranulin gene variants in Alzheimer’s disease.

Journal of Neurology 255, Suppl. 2: 47 (2008). XVIII Meeting of the European

Neurological Society, June 7-11, 2008, Nice, France.

149. Carecchio M, Comi C, Nicola S, Galimberti D, Chiocchetti A, Fenoglio C, Cappellano

G, Scarpini E, Monaco F, Dianzani U. Osteopontin is increased in the cerebrospinal

fluid of patients with early Alzheimer’s disease and its levels correlate with cognitive

deterioration. Journal of Neurology 255, Suppl. 2: 47 (2008). XVIII Meeting of the

European Neurological Society, June 7-11, 2008, Nice, France.

150. De Riz M, Fenoglio C, Scalabrini D, Comi C, Pietroboni A, Venturelli E, Cortini F,

Villa C, Serpente M, Leone M, Monaco F, Bresolin N, Galimberti D, Scarpini E.

Progranulin gene mutation scanning in multiple sclerosis patients with cognitive

impairment. Journal of Neurology 255, Suppl. 2: 144 (2008). XVIII Meeting of the


151. Lovati C, Cislaghi G, Galimberti D, Bertora P, Fenoglio C, Scarpini E, Mariani C.

Distribution of ApoE alleles in different kinds of mild cognitive impairment. Journal

of Neurology 255, Suppl. 2: 193-194 (2008). XVIII Meeting of the European

Neurological Society, June 7-11, 2008, Nice, France.

152. Lovati C, Pesaresi M, Clerici F, Albani D, Galimberti D, Venturelli E, Forloni G,

Mariani C. Analysis of the prevalence of behavioural and psychiatric disorders among

Alzheimer’s disease patients with and without PLAU1 polymorphism. Journal of

Neurology 255, Suppl. 2: 194 (2008). XVIII Meeting of the European Neurological


153. Venturelli E, Fenoglio C, Cortini F, Scalabrini D, Villa C, Guidi I, Mandelli A,

Marcone A, Perini L, Pomati S, Clerici F, Cappa S, Mariani C, Bresolin N, Scarpini E,

Galimberti D. Progranulin gene mutation scanning in Alzheimer’s disease and

Pagina 25 di 33


frontotemporal lobar degeneration: functional and phenotypic correlations. Journal of

Neurology 255, Suppl. 2: 194 (2008). XVIII Meeting of the European Neurological


154. Scalabrini D, Fenoglio C, Piccio L, Cross A, De Riz M, Venturelli E, Cortini F, Villa

C, Piola M, Parks B, Rinker J, Bresolin N, Scarpini E, Galimberti D. Selectin gene

cluster genetic variation: association study in two independent multiple sclerosis

populations. Journal of Neurology 255, Suppl. 2: 178 (2008). XVIII Meeting of the


155. Cortini F, Fenoglio C, Guidi I, Venturelli E, Pomati S, Marcone A, Scalabrini D, Villa

C, Clerici F, Dalla Valle E, Mariani C, Cappa S, Bresolin N, Scarpini E, Galimberti D.

Novel exon 1 progranulin gene variations in Alzheimer’s disease and frontotemporal

lobar degeneration. Clinical Neuropathology 27(4): 264-265 (2008). XLIV Annual

Meeting of the Italian Association of Neuropathology (AINP) – XXXIV Meeting of

the Italian Association for Resesrch on Brain Aging (AIRIC), June 18-21, 2008, Milan,

Italy.

156. Fenoglio C, Galimberti D, Cortini F, Kauwe JSK, Venturelli E, Scalabrini D, Lovati C,

Villa C, Restelli I, Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Scarpini E.

Genetic and functional analysis of progranulin gene variants in Alzheimer’s disease.

Clinical Neuropathology 27(4): 266 (2008). XLIV Annual Meeting of the Italian

Association of Neuropathology (AINP) – XXXIV Meeting of the Italian Association

for Resesrch on Brain Aging (AIRIC), June 18-21, 2008, Milan, Italy.

157. Lovati C, Galimberti D, Cislaghi G, Bertora P, Clerici F, Guidi I, Venturelli E,

Scarpini E, Mariani C. APOE in different forms of MCI. Clinical Neuropathology

27(4): 271 (2008). XLIV Annual Meeting of the Italian Association of Neuropathology

(AINP) – XXXIV Meeting of the Italian Association for Resesrch on Brain Aging

(AIRIC), June 18-21, 2008, Milan, Italy.

158. Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E, Corini F, Villa C, Serpente

M, Piola M, Pietroboni A, Monaco F, Bresolin N, Galimberti D, Scarpini E.

Progranulin gene mutation scannino in Multiple Sclerosis patients with cognitive

impairment. Clinical Neuropathology 27(4): 279-280 (2008). XLIV Annual Meeting

of the Italian Association of Neuropathology (AINP) – XXXIV Meeting of the Italian

Association for Resesrch on Brain Aging (AIRIC), June 18-21, 2008, Milan, Italy.

159. Scarpini E, Galimberti D. Biological markers in Alzheimer’s disease and other

neurodegenerative disorders: genetics. Clinical Neuropathology 27(4): 280 (2008).

XLIV Annual Meeting of the Italian Association of Neuropathology (AINP) – XXXIV

Meeting of the Italian Association for Resesrch on Brain Aging (AIRIC), June 18-21,

2008, Milan, Italy.

160. Venturelli E, Villa C, Fenoglio C, Lovati C, Marcone A, Ghidoni R, Cortini F,

Scalabrini D, Mandelli A, Binetti G, Cappa S, Mariani C, Bresolin N, Scarpini E,

Galimberti D. The NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal

lobar degeneration. Clinical Neuropathology 27(4): 284 (2008). XLIV Annual

Meeting of the Italian Association of Neuropathology (AINP) – XXXIV Meeting of

the Italian Association for Resesrch on Brain Aging (AIRIC), June 18-21, 2008, Milan,

Italy.

161. Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L, Cortini F,

Scalabrini D, Perini L, Binetti G, Cappa S, Mariani C, Bresolin N, Scarpini E,

Galimberti D. The MCP-1 A-2518G polymorphism acts as protective factor for

frontotemporal lobar degeneration. Clinical Neuropathology 27(4): 285 (2008). XLIV

Annual Meeting of the Italian Association of Neuropathology (AINP) – XXXIV

Meeting of the Italian Association for Resesrch on Brain Aging (AIRIC), June 18-21,

2008, Milan, Italy.

162. Kauwe JSK, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D,

Scarpini E, Shan AR, Morris JC, Fagan AM, Holtzman DM, Goate AM. SNPs in

MAPT are associated wit cerebrospinal fluid tau levels, MAPT mRNA levels, and age

at onset of late-onset Alzheimer’s disease. Alzheimer’s & Dementia 2008; 4(4)Suppl.

2: T145. Alzheimer’s Association International Conference on Alzheimer’s disease,

July 26-31, Chicago, IL, USA.

163. Scarpini E, Lovati C, Cislaghi G, Suardelli M, Rosa S, Galimberti D, Mariani C. ApoE

alleles distribution in different forms of Mild Cognitive Impairment. Alzheimer’s &

Dementia 2008; 4(4)Suppl. 2: T270. Alzheimer’s Association International

Conference on Alzheimer’s disease, July 26-31, Chicago, IL, USA.

Pagina 26 di 33


164. Fenoglio C, Cortini F, Venturelli E, Guidi I, Scalabrini D, Villa C, Kauwe JSK, Mayo

K, Dalla Valle E, Lovati C, Mariani C, Scarpini E, Bresolin N, Goate AM, Galimberti

D. Genetic and functional analysis of progranulin gene variants in patients with

Alzheimer’s disease. Alzheimer’s & Dementia 2008; 4(4)Suppl. 2: T584.

Alzheimer’s Association International Conference on Alzheimer’s disease, July 26-31,

Chicago, IL, USA.

165. Galimberti D, Fenoglio C, Cortini F, Venturelli E, Guidi I, Scalabrini D, Villa C,

Marcone A, Mandelli A, Perini L, Pomati S, Clerici F, Cappa S, Mariani C, Bresolin

N, Scarpini E. Progranulin gene mutation scanning in Alzheimer’s disease and

Frontotemporal Lobar Degeneration: functional and phenotypic correlations.

Alzheimer’s & Dementia 2008; 4(4)Suppl. 2: 585. Alzheimer’s Association

International Conference on Alzheimer’s disease, July 26-31, Chicago, IL, USA.

166. Borroni B, Ghezzi S, Agosti C, Archetti S, Fenoglio C, Galimberti D, Scarpini E, Di

Luca M, Bresolin N, Comi GP, Padovani A, Del Bo R. Vascular Endothelial Growth

Factor genetic variability conferì susceptibility to Frontotemporal Lobar Degeneration.

Dementia and Geriatric Cognitive Disorders 2008; 26(Suppl.1): 49. 6th

International Conference on Frontotemporal Dementias, September 3-5, 2008,

Rotterdam, The Netherlands.

167. Galimberti D, Fenoglio C, Cortini F, Kauwe J, Venturelli E, Scalabrini D, Villa C,

Mayo K, Piccio L, Clerici F, Albani D, Mariani C, Forloni G, Bresolin N, Goate A,

Scarpini E. PGRN genetic variability in Alzheimer’s disease: effect on susceptibility,

age at onset and mRNA levels. Neurological Sciences 29, Suppl.: S7, 2008. XXXIX

Congress of the Italian Neurological Society, October 18-22, 2008, Naples, Italy.

168. Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L,

Cortini F, Scalabrini D, Restelli I, Binetti G, Cappa S, Mariani C, Bresolin N, Scarpini

E. The MCP-1 A-2518G polymorphism acts as protective factor for Frontotemporal

Lobar Degeneration. Neurological Sciences 29, Suppl.: S181, 2008. XXXIX Congress

of the Italian Neurological Society, October 18-22, 2008, Naples, Italy.

169. Lovati C, Cislaghi G, Capiluppi E, Galimberti D, Ratti P, Clerici F, Venturelli E,

Vanotti A, Rosa S, Bertora P, Scarpini E, Mariani C. ApoE and family history in

different forms of cognitive decline. Neurological Sciences 29, Suppl.: S264-265,

2008. XXXIX Congress of the Italian Neurological Society, October 18-22, 2008,

Naples, Italy.

170. Bigni B, Archetti S, Alberici A, Agosti C, Gennarelli M, Bonvicini C, Ferrari M,

Belleli G, Galimberti D, Scarpini E, Di Lorenzo D, Caimi L, Caltagirone C, Di Luca

M, Borroni B, Padovani A. Progranulin mutation in Frontotemporal Lobar

Degeneration: an Italian clinical series. XII Congresso ITINAD, Milano, 9 Gennaio

2009.

171. Cortini F, Fenoglio C, Venturelli E, Pomati S, Marcone A, Scalabrini D, Villa C,

Serpente M, Clerici F, Mariani C, Cappa S, Bresolin N, Scarpini E, Galimberti D. Novel exon 1 progranulin gene variant in Alzheimer’s disease. XII Congresso

ITINAD, Milano, 9 Gennaio 2009.

172. Del Bo R, Ghezzi S, Corti S, Santoro D, Briani C, Mancuso M, Siciliano G,

Fenoglio C, Galimberti D, Scarpini E, Bresolin N, Comi GP. Progranulin genotyping in 237 sporadic amyothropic lateral sclerosis patients. XII Congresso

ITINAD, Milano, 9 Gennaio 2009.

173. Scalabrini D, Fenoglio C, Martinelli Boneschi F, De Riz M, Esposito F, Piccio

LM, Venturelli E, Cortini F, Villa C, Serpente M, Piola M, Pietroboni A, Bresolin N, Cross A, Galimberti D, Scarpini E. GRN rs5848 in neurodegeneration: a role in axonal damage? XII Congresso ITINAD, Milano, 9 Gennaio 2009.

174. Serpente M, Fenoglio C, Cortini F, Kauwe JSK, Cruchaga C, Venturelli E,

Scalabrini D, Villa C, Mayo K, Piccio LM, Clerici F, Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Galimberti D, Scarpini E. rs5848 variant influences GRN mRNA levels in patients with Alzheimer’s disease. XII Congresso ITINAD,

Milano, 9 Gennaio 2009.

175. Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Ghidoni R, Cortini F,

Scalabrini D, Gallone S, Rainero I, Restelli I, Serpente M, Binetti G, Cappa S, Mariani C, Giordana MT, Bresolin N, Scarpini E, Galimberti D. The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for Frontotemporal Lobar

Pagina 27 di 33


Degeneration. XII Congresso ITINAD, Milano, 9 Gennaio 2009.

176. Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L, Cortini F,

Scalabrini D, Serpente M, Restelli I, Binetti G, Cappa S, Mariani C, Bresolin N, Scarpini E, Galimberti D. MCP-1 A-2518G polymorphism: effect on susceptibility for Frontotemporal Lobar Degeneration and on cerebrospinal fluid MCP-1 levels. XII Congresso ITINAD, Milano, 9 Gennaio 2009.

177. Scalabrino G, Galimberti D, Mutti E, Scalabrini D, Veber D, De Riz M, Bamonti F,

Capello E, Mancardi GL, Scarpini E. Loss of cobalamin-mediated regulation leads to

decreased EGF and increased solubile CD40 levels in cerebrospinal fluid of patients

with multiple sclerosis. Neurology 72(11):Suppl 3(2009): P01.116 (A37). 61st

American Academy of Neurology (AAN), Seattle, April 25-May 2, 2009.

178. Lovati C, Galimberti D, Mariani C. Low dose-topiramate-induced acute bilateral reversibile glaucoma: a case report. Neurology 72(11):Suppl 3(2009):

P06.010 (A286). 61st American Academy of Neurology (AAN), Seattle, April 25-May 2, 2009.

179. Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L,

Ghidoni R, Cortini F, Scalabrini D, Serpente M, Restelli I, Binetti G, Cappa S, Mariani C, Bresolin N, Scarpini E. MCP-1 A-2518G polymorphism: effect on susceptibility for Frontotemporal Lobar Degeneration and on cerebrospinal fluid MCP-1 level. Neurology 72(11):Suppl 3(2009): P07.021 (A330). 61st

American Academy of Neurology (AAN), Seattle, April 25-May 2, 2009.

180. Fenoglio C, Martinelli Boneschi F, Galimberti D, Scalabrini D, Esposito F, De Riz M, Piccio LM, Naismith R, Parks BJ, Comi C, Pietroboni A, Piola M, Venturelli E, Cortini F, Villa C, Serpente M, Monaco F, Bresolin N, Cross AH, Scarpini E. Progranulin gene variability in a population of 239 patients with primary progressive multiple sclerosis. Neurology 72(11):Suppl 3(2009):

P08.029 (A373-4). 61st American Academy of Neurology (AAN), Seattle, April 25-May 2, 2009.

181. Galimberti D, Fenoglio C, Cortini F, Kauwe JSK, Cruchaga C, Venturelli E,

Scalabrini D, Villa C, Serpente M, Mayo K, Piccio LM, Clerici F, Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Scarpini E. rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells from patients with Alzheimer’s disease. Neurology 72(11):Suppl 3(2009): P08.083

(A386). 61st American Academy of Neurology (AAN), Seattle, April 25-May 2, 2009.

182. Albani D, Prato F, Tettamanti M, Lovati C, Galimberti D, Restelli I, Mariani C,

Quadri PL, Scarpini E, Lucca U, Forloni G. The serotonin transporter promoter polymorphic region as risk factor for Alzheimer’s disease related behavioral disturbances. Clinical Neuropathology 28(3): 219 (2009). XLV Annual Meeting of

the Italian Association of Neuropathology (AINP) – XXXV Meeting of the Italian

Association for Research on Brain Aging (AIRIC), June 3-6, 2009, Bologna, Italy.

183. Cortini F, Fenoglio C, Venturelli E, Villa C, Clerici F, Albani D, Scalabrini D, Serpente M, Mariani C, Forloni G, Bresolin N, Scarpini E, Galimberti D. CDKN2A and CDKN2B genetic variability in Alzheimer’s disease patients. Clinical Neuropathology 28(3): 225 (2009). XLV Annual Meeting of the Italian

Association of Neuropathology (AINP) – XXXV Meeting of the Italian Association

for Research on Brain Aging (AIRIC), June 3-6, 2009, Bologna, Italy.

184. Scalabrini D, Fenoglio C, Martinelli Boneschi F, De Riz M, Esposito F,

Venturelli E, Cortini F, Villa C, Serpente M, Piola M, Pietroboni A, Bresolin N, Galimberti D, Scarpini E. GRN rs5848 polymorphism: a role in neurodegeneration? Clinical Neuropathology 28(3): 240 (2009). XLV Annual

Meeting of the Italian Association of Neuropathology (AINP) – XXXV Meeting of the

Italian Association for Research on Brain Aging (AIRIC), June 3-6, 2009, Bologna,

Italy.

185. Venturelli E, Fenoglio C, Cortini F, Serpente M, Kauwe JSK, Cruchaga C, Scalabrini

D, Villa C, Mayo K, Piccio L, Clerici F, Albani D, Mariani C, Forloni G, Bresolin N,

Goate AM, Galimberti D, Scarpini E. rs5848 variant influences GRN expression in

brain and blood cells from patients with AD. Clinical Neuropathology 28(3): 243

(2009). XLV Annual Meeting of the Italian Association of Neuropathology (AINP) –

XXXV Meeting of the Italian Association for Research on Brain Aging (AIRIC), June

3-6, 2009, Bologna, Italy.

Pagina 28 di 33


186. Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L, Ghidoni R,

Gallone S, Cortini F, Scalabrini D, Binetti G, Rainero I, Giordana MT, Cappa S, Mariani C, Bresolin N, Scarpini E, Galimberti D. KIF24 gene is associated with frontotemporal lobar degeneration. Clinical Neuropathology 28(3): 244 (2009).

XLV Annual Meeting of the Italian Association of Neuropathology (AINP) – XXXV

Meeting of the Italian Association for Research on Brain Aging (AIRIC), June 3-6,

2009, Bologna, Italy.

187. Galimberti D, Fenoglio C, Serpente M, Cortini F, Kauwe J, Cruchaga C, Venturelli E,

Scalabrini D, Villa C, Mayo K, Piccio L, Clerici F, Albani D, Mariani C, Forloni G,

Bresolin N, Goate A, Scarpini E. rs5848 variant influences GRN mRNA levels in brain

and peripheral mononuclear cells from patients with Alzheimer’s disease. Journal of

Neurology 256, Suppl. 2: S57 (2009). XIX Meeting of the European Neurological

Society, June 20-24, 2009, Milan, Italy.

188. Piccio L, Buonsanti C, Naismith R, Schmidt R, Fenoglio C, Galimberti D, Scarpini E, Panina P, Passini N, Colonna M, Cross A. TREM-2 and TREM-1 expression in the central nervous system and possible function in modulating inflammation during MS. Journal of Neurology 256, Suppl. 2: S86 (2009). XIX

Meeting of the European Neurological Society, June 20-24, 2009, Milan, Italy.

189. Fenoglio C, Galimberti D, Martinelli-Boneschi F, Scalabrini D, Esposito F, De Riz M, Piccio L, Comi C, Pietroboni A, Piola M, Venturelli E, Cortini F, Villa C, Serpente M, Leone M, Bresolin N, Cross A, Comi G, Scarpini E. Progranulin genetic variability in primary progressive multiple sclerosis. Journal of

Neurology 256, Suppl. 2: S235 (2009). XIX Meeting of the European Neurological

Society, June 20-24, 2009, Milan, Italy.

190. De Riz M, Galimberti D, Fenoglio C, Piccio L, Pietroboni A, Piola M, Scalabrini D,

Venturelli E, Bresolin N, Cross A, Scarpini E. Cerebrospinal fluid progranulin levels

in patients with different multiple sclerosis subtypes. Multiple Sclerosis 2009; 15,

Suppl. 2: S79-80. 25rd Congress of the European Committee for Treatment and

Research in Multiple Sclerosis (ECTRIMS), September 9-12, 2009, Dusseldorf,

Germany.

191. Fenoglio C, Esposito F, Galimberti D, Scalabrini D, Martinelli V, Rodegher ME, De

Riz M, Piccio L, Comi C, Venturelli E, Cortini F, Villa C, Bresolin N, Cross A, Comi

G, Scarpini E, Martinelli-Boneschi F. Progranulin genetic variability in primary progressive multiple sclerosis. Multiple Sclerosis 2009; 15, Suppl. 2: S187. 25rd


Sclerosis (ECTRIMS), September 9-12, 2009, Dusseldorf, Germany.

192. Piccio L, Buonsanti C, Naismith R, Parks B, Fenoglio C, Galimberti D, Scarpini E,

Panina P, Passini N, Colonna M, Cross A. TREM-2 and TREM-1 as

immunoregulatory molecole in multiple sclerosis. Multiple Sclerosis 2009; 15, Suppl.

2: S190. 25rd Congress of the European Committee for Treatment and Research in

Multiple Sclerosis (ECTRIMS), September 9-12, 2009, Dusseldorf, Germany.

193. Galimberti D, Martinelli Boneschi F, Fenoglio C, Scalabrini D, Esposito F, De

Riz M, Piccio L, Comi C, Pietroboni A, Piola M, Venturelli E, Cortini F, Villa C, Serpente M, Leone M, Comi G, Bresolin N, Cross A, Scarpini E. Progranulin gene variability in patients with primary progressive multiple sclerosis. European Journal of Neurology 2009; 16 Suppl. 3: 255. 13th Congress of

the European Federation of Neurological Societies, September 12-15, 2009, Florence, Italy.

194. Galimberti D, Fenoglio C, Cortini F, Serpente M, Kauwe J, Cruchaga C,

Venturelli E, Scalabrini D, Villa C, Mayo K, Piccio L, Clerici F, Albani D, Mariani C, Forloni G, Bresolin N, Goate A, Scarpini E. rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells from patients with Alzheimer’s disease. European Journal of Neurology 2009; 16 Suppl. 3:

336. 13th Congress of the European Federation of Neurological Societies, September 12-15, 2009, Florence, Italy.

195. Galimberti D, Fenoglio C, Cortini F, Serpente M, Venturelli E, Villa C, Clerici F,

Marcone A, Benussi L, Ghidoni R, Gallone S, Scalabrini D, Restelli I, Martinelli Boneschi F, Cappa S, Binetti G, Mariani C, Rainero I, Giordana M, Bresolin N, Scarpini E. GRN variability contributes to sporadic frontotemporal lobar degeneration. Neurological Sciences 30, Suppl.: S4, 2009. XL Congress of

the Italian Neurological Society, November 21-25, 2009, Padova, Italy.

Pagina 29 di 33


196. De Riz M, Galimberti D, Fenoglio C, Piccio L, Pietroboni A, Piola M, Scalabrini

D, Venturelli E, Bresolin N, Cross A, Scarpini E. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neurological Sciences 30, Suppl.: S71-2, 2009. XL Congress of the Italian Neurological

Society, November 21-25, 2009, Padova, Italy.

197. Cova I, Fusari Imperatori S, Pomati S, Maggiore L, Cucumo V, Finotto S, Venturelli E, Galimberti D, Scarpini E, Clerici F, Mariani C. Vascular risk factors do not individually affect risk of conversion of mild cognitive impairment to dementia. Neurological Sciences 30, Suppl.: S340, 2009. XL Congress of the

Italian Neurological Society, November 21-25, 2009, Padova, Italy.

198. Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Scalabrini D, Cortini F, Cappa S, Binetti G, Mariani C, Rainero I, Giordana M, Bresolin N, Scarpini E. KIF24 single nucleotide polymorphism is a risk factor for sporadic frontotemporal lobar de generation. Neurological Sciences 30, Suppl.: S349, 2009. XL Congress of the Italian

Neurological Society, November 21-25, 2009, Padova, Italy.

199. Borroni B, Bonvivini C, Galimberti D, Tremolizzo L, papetti A, Silvana A, Turla M, Alberici A, Agosti C, Rianiero I, Ferrarese C, Gennarelli M, Scarpini E, Padovani A. Effetto fondatore ed eterogeneità clinica della mutazione T272SfsX10 del gene progranulina in 14 famiglie italiane affette da degenerazione lobare frontotemporale. Neurological Sciences 31: S77,

2009. V Congresso Sindem, Firenze, 18-20 Marzo 2010.

200. Clerici F, Caracciolo B, Cova I, Fusari Imperatori S, Maggiore L, Galimberti D, Scarpini E, Mariani C, Fratiglioni L. L’impatto del carico vascolare sulla progressione del MCI a demenza. Neurological Sciences 31: S82-3, 2009. V

Congresso Sindem, Firenze, 18-20 Marzo 2010.

201. Cova I, Caracciolo B, Fusari Imperatori S, Pomati S, Cucumo V, Galimberti D, scarpini E, Clerici F, mariani C, Fratiglioni L. Un basso indice di massa corporea (BMI) aumenta il rischio di progressione da MCI a demenza e malattia di Alzheimer. Neurological Sciences 31: S84, 2009. V Congresso

Sindem, Firenze, 18-20 Marzo 2010.

202. Fenoglio C, Galimberti D, Cantoni C, Cortini F, Venturelli E, Villa C, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Scalabrini D, Franceschi M, Cappa S, Binetti G, Mariani C, Rainero I, Giordana MT, Bresolin N, Scarpini E. Influenza della variabilità genetica di FUS/TLS nell’insorgenza della degenerazione lobare frontotemporale. Neurological Sciences 31: S86,


203. Galimberti D, Rotondo E, Vimercati R, Corti P, Bergamaschini L, Fenoglio C, Serpente M, Cantoni C, De Riz M, Bresolin N, Vergani C, Scarpini E. profilo neuropsicologico e correlazione con i livelli liquorali delle proteine amiloide, tau e fosfotau in soggettii con decadimento cognitivo lieve. Neurological Sciences 31: S88, 2009. V Congresso Sindem, Firenze, 18-20 Marzo 2010.

204. Rainero I, Rubino E, Gallone S, Fenoglio P, Galimberti D, Scarpini E, Pinessi

L. Sequenziamento del gene P62/SQSTM1 in pazienti affetti da degenerazione lobare frontotemporale. Neurological Sciences 31: S98,


205. Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Scalabrini D, Cortini F, Cappa S, Binetti G, franceschi M, Rainero I, Giordana MT, Mariani C, Bresolin N, Scarpini E, Galimberti D. Cromosoma 9 e degenerazione lobare frontotemporale sporadica: KIF24, ma non UBAP1, è un fattore di rischio nella popolazione italiana. Neurological Sciences 31: S106,


COMUNICAZIONI ORALI A CONGRESSI INTERNAZIONALI

o “Chemokine levels in CSF and serum from patients with different types of dementia”.

XII Meeting of the European Neurological Society, June 22-26, 2002, Berlin, Germany.

o “CC chemokine receptor gene polymorphisms in patients with Alzheimer’s disease”.

Pagina 30 di 33


XIII Meeting of the European Neurological Society, June 14-18, 2003, Istanbul, Turkey.

o “E-selectin G98T and A561C single nucleotide polymorphisms in patients with

multiple sclerosis”. 56th Meeting of the American Academy of Neurology, S.

Francisco, USA, April 24th-May 1st, 2004.

o “Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease”.

XVI Meeting of the European Neurological Society, May 27-31, 2006, Lausanne,

Switzerland.

o “Chemokine serum levels in mild cognitive impairment as Alzheimer’s disease early

biomarkers”. 10th Congress of the European Federation of Neurological Societies,

September 2-5, 2006, Glasgow, UK.

o “ApoE e2 decreases the susceptibility to develop Alzheimer’s disease but not

frontotemporal lobar degeneration, Lewy body disease or vascular dementia”. XVII

Meeting of the European Neurological Society, June 16-20, 2007, Rhodes, Greece.

o Progranulin gene mutation scanning in Italian Alzheimer’s disease population. XVII

Meeting of the European Neurological Society, June 16-20, 2007, Rhodes, Greece.

o Progranulin Gene Mutation Scanning and Expression Analysis in Patients with

Alzheimer s Disease. 60th Meeting of the American Academy of Neurology, Chicago,

USA, April 12-19, 2008.

o rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear

cells from patients with Alzheimer’s disease. XIX Meeting of the European

Neurological Society, June 20-24, 2009, Milan, Italy.

COMUNICAZIONI ORALI A CONGRESSI NAZIONALI

“Effect of amyloid-associated proteins on proinflammatory function of cultured human

monocytes and mouse microglia”.

XXXIII Annual Meeting of the Italian Neuropathological Association, 1997, Pisa,

Italy

-melanocyte stimulating hormone inhibits production of nitric oxide by -amyloid

activated microglia”.

XXXIV Annual Meeting of the Italian Neuropathological Association, 1998, Bosisio

Parini, Italy

“IP-10 and MCP-1 in serum and CSF: possible immunological markers in multiple

sclerosis”.

XXXVII Annual Meeting of the Italian Neuropathological Association, May 24-26,

2001, Verbania, Italy

“Chemokine levels in CSF and serum from demented patients”.

XXXVIII Annual Meeting of the Italian Neuropathological Association, May 2002,

Napoli, Italy.

“CC chemokine receptor gene polymorphisms in patients with Alzheimer’s disease”.

Congresso ITINAD, Sorrento, 22-24 Maggio 2003.

“CCR2∆32 and CCR5-64I gene polymorphisms in patients with Alzheimer’s

disease”.

XXXIX Annual Meeting of the Italian Association of Neuropathology (AINP), June 9-

12, 2003, Siena, Italy.

“CCR2-64I and CCR5 gene polymorphisms in patients with Alzheimer’s disease”.

XXXIV Congress of the Italian Neurological Society, October 11-15, 2003, Rome, Italy.


40th Annual Meeting of the Italian Association of Neuropathology (AINP) May 24-26,

2004, Padova, Italy

CSF chemokine levels: differences among MCI, AD and FTLD patients. Implication

in AD pathogenesis and possible relevance for early diagnosis. 41st Annual Meeting of

Pagina 31 di 33


the Italian Association of Neuropathology (AINP) jointly with the French Society of

Neuropathology – 31st Meeting of the Italian Association for Research on Brain Aging

(AIRIC), May 26-28, 2005, Saluzzo, Italy.

Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease. 42nd

Annual Meeting of the Italian Association of Neuropathology (AINP) – 32nd Meeting

of the Italian Association for Resesrch on Brain Aging (AIRIC), May 24-27, 2006,

Rome Italy.

Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease.

XXXVII Congress of the Italian Neurological Society, October 14-18, 2006, Bari,

Italy.

ApoE e2 and e4 influence the susceptibility for Alzheimer’s disease but not other

dementias. XXXVIII Congress of the Italian Neurological Society, October 13-17,


Intrathecal levels of IL-6, IL-11, LIF, and A42, tau and phosphotau biomarkers in

Alzheimer’s disease and Frontotemporal Lobar Degeneration.. XXXVIII Congress of

the Italian Neurological Society, October 13-17, 2007, Firenze, Italy.

GRN variability contributes to sporadic frontotemporal lobar degeneration. XL Congress of the Italian Neurological Society, November 21-25, 2009, Padova, Italy.

RELAZIONI SU INVITO

- Round Table: “From basic mechanisms to new therapeutic approaches”.

XXXVII Annual Meeting of the Italian Neuropathological Association, Teaching

course on demyelinating diseases “Demyelination in PNS and CNS: basic mechanisms

and advances in treatment” May 23, 2001, Verbania, Italy

- “Molecular mechanisms controlling lymphocyte recruitment into the Central Nervous

System”

A tribute to Professor Guglielmo Scarlato - “Immunology of Multiple Sclerosis: from

molecular pathogenesis to treatment” –, February 1st, 2003, Milan, Italy.

- “Fattori immunologici e genetici di suscettibilità alla Sclerosi Multipla” – Malattie

Demielinizzanti, corso biennale, I anno: Aspetti patogenetici e diagnostici, Milano, 2-5

Marzo 2004.

- “Aspetti pratici del laboratorio di farmaco- e immuno-genetica” – Malattie

Demielinizzanti, corso biennale, II anno: Aspetti prognostici e terapeutici, Milano, 2-4

Marzo 2005.

- “Present and future of genetics in MS: from gene to therapy” – Open seminar

nell’ambito del II anno del corso biennale sulle Malattie Demielinizzanti, Milano, 4

Marzo 2005.

- Sintesi intratecale di chemochine nel decadimento cognitivo lieve e nella malattia di

Alzheimer. 3rd Annual Meeting on Brain Aging and Dementia. Brescia, 2 Dicembre

2005.

- Marcatori precoci biologici liquorali e periferici – Giornata monotematica Centro di

Eccellenza per le Malattie Neurodegenerative – Fondazione Monzino dal titolo:

“Nuove acquisizioni nella neurobiologia della malattia di Alzheimer: implicazioni

pratiche per una diagnosi ed un trattamento precoci” – Milano, 28 Ottobre 2006.

- Dementia and higher function disorders – AAN-ENS joint teaching course. “Genetics

and molecular biology of AD and related neurodegenerative disorders” XVIII Meeting

of the European Neurological Society, June 7-11, 2008, Nice, France.

- Cerebrospinal fluid biomarkers – Symposium on neurodegenerative mechanisms in

Alzheimer’s disease, June 23, 2008, Milan, Italy.

- Workshop on Mild Cognitive Impairment – “Genetic and biological aspects” - XIX

Meeting of the European Neurological Society, June 20-24, 2009, Milan, Italy.

- Simposio Associazone demenze-SIN-DEM dal titolo: “Meccanismi neurodegenerativi

Pagina 32 di 33


nella patogenesi della demenza”, XL Congresso della Società Italiana di Neurologia,

Padova, 23 Novembre 2009. Titolo della relazione: “Genetica e biologia molecolare

della degenerazione lobare frontotemporale. Analogie e differenze con altre patologie

neurodegenerative”.


ORGANIZZAZIONE CORSI

- Malattie Demielinizzanti, corso biennale, I anno: Aspetti

patogenetici e diagnostici, Milano, 2-5 Marzo 2004 – Segreteria

Organizzativa

- Malattie Demielinizzanti, corso biennale, II anno: Aspetti

prognostici e terapeutici, Milano, 2-4 Marzo 2005 - Segreteria

Organizzativa


CHAIRMAN

- XII Meeting of the European Neurological Society, June 22-26, 2002, Berlin, Germany, oral session “Higher functions disorders”.

- XVII Meeting of the European Neurological Society, June 16-20, 2007, Rhodes, Greece, oral session “Dementia”

- XVII Meeting of the European Neurological Society, June 16-20, 2007, Rhodes, Greece, poster session “Dementia/Higher function disorders”.

- XVIII Meeting of the European Neurological Society, June 7-11, 2008, Nice, France, poster session “Dementia”.

- XIX Meeting of the European Neurological Society, June 20-24, 2009, Milan,

Italy, Oral Session on Higher function disorders.

- XIX Meeting of the European Neurological Society, June 20-24, 2009, Milan,

Italy. Poster session on Dementia/ Higher function disorders.


REVISORE RIVISTE SCIENTIFICHE

- Jounal of the Neurological Sciences

- Cytokine

- Journal of Cellular and Molecular Medicine

- Neurotoxicity Research

- Journal of Neuroimmunology

- Neuroscience Letters

- Human Immunology

- Clinical and Experimental Medicine

- Neurobiology of Disease

- Experimental Neurology

Pagina 33 di 33


- Editorial Board Member della rivista “The Open Geriatric Medicine Journal”

- Senior Editor della rivista “Journal of Alzheimer Disease”

- Editorial Board member della rivista “International Journal of Clinical and Experimental Medicine”


PREMI

2006: SINDEM – Miglior contributo presentato al congresso Nazionale della SIN-demenze (sponsorizzato dalla Associazione per la Ricerca sulle Demenze)

2006: Best of Free Communication- XVI Meeting of the European Neurological Society,

May 27-31, 2006, Lausanne, Switzerland.


MEMBERSHIP SOCIETA’ SCIENTIFICHE

AIRIC (Associazione Italiana per la Ricerca sull’Invecchiamento Cerebrale)

ENS (European Neurological Association)

Chair della ENS subcommittee on Behavioural and cognitive neurology & Dementia

Milano 27/6/2016

Il sottoscritto è a conoscenza che, ai sensi dell’art. 26 della legge 15/68, le dichiarazioni mendaci, la falsità negli atti e l’uso di atti falsi sono puniti ai sensi del codice penale e delle leggi speciali. Inoltre, il sottoscritto autorizza al trattamento dei dati personali, secondo quanto previsto dalla Legge 196/03.

FORMATO EUROPEO PER IL CURRICULUM...

Documents

Transcript of FORMATO EUROPEO PER IL CURRICULUM...